CURRICULUM VITAE - University of...

CURRICULUM VITAE 1. March 1, 2016 PERSONAL: 2. Name: David Steven Greenfield, M.D. 3. Home Phone: 4. Office Phone: (561) 515-1513 5. Home Address: 6. Current Academic Rank: Professor of Ophthalmology 7. Primary Department: Ophthalmology 8. Secondary or Joint Appointments: None 9. Citizenship: U.S.A. 10. Visa: Not Applicable. HIGHER EDUCATION: 11. Institutional:

1995: Clinical Fellow, Neuro-Ophthalmology, Bascom Palmer Eye Institute, University of Miami School of Medicine, Miami, FL 1995: Heed-Knapp Fellow, Neuro-Ophthalmology, Bascom Palmer Eye Institute, University of Miami School of Medicine, Miami, FL 1994 - 1995: Clinical Fellow, Glaucoma, Bascom Palmer Eye Institute, University of Miami School of Medicine, Miami, FL 1994 - 1995: Heed Fellow, Glaucoma, Bascom Palmer Eye Institute, University of Miami School of Medicine, Miami, FL

1991 - 1994: Resident, Subject: Ophthalmology, New England Eye Center, Tufts University School of Medicine, Boston, MA

1990 - 1991: Intern, Internal Medicine, Beth Israel Medical Center, New York City, NY 1986 - 1990: M.D., New York University School of Medicine, New York City, NY 1982 - 1986: Bachelor of Arts - Biology, Magna Cum Laude New York University - Washington Square and University College, New York City, NY 1979 - 1982: Stuyvesant High School, New York City, NY 12. Non-Institutional: Not Applicable.

13. Certification and Licensure:

1996 - Present: Diplomate, American Board of Ophthalmology (Re-certification 11/26/2014) 1995 - Present: State of New York Medical Licensure, #201306 1994 - Present: State of Florida Medical Licensure, #ME0066425 1992 - Present: Commonwealth of Massachusetts Medical Licensure, #75334 1991 - Present: Diplomate, National Board of Medical Examiners

2

EXPERIENCE: 14. Academic: 2006 – Present: Professor of Ophthalmology, University of Miami Miller School of Medicine, Bascom

Palmer Eye Institute, Miami, FL. 2002 - Present Associate Professor of Ophthalmology, University of Miami Miller School of Medicine, Bascom Palmer Eye Institute, Miami, FL 2001 – 2002 Assistant Professor of Ophthalmology, University of Miami Miller School of Medicine, Bascom Palmer Eye Institute, Miami, FL 1997 - 2001: Assistant Professor of Clinical Ophthalmology, University of Miami Miller School of Medicine, Bascom Palmer Eye Institute, Miami, FL 1996 - 1997: Clinical Assistant Professor of Ophthalmology, New York Medical College, Valhalla, NY, and The New York Eye & Ear Infirmary, New York. 1996 - 1997: Clinical Assistant Professor of Neurology, New York Medical College,

Valhalla, NY and The New York Eye & Ear Infirmary, New York., NY 15. Hospital Appointments: 1997 – Present: Jackson Memorial Hospital, University of Miami Miller School of Medicine 1997 – Present: Anne Bates Leach Eye Hospital, University of Miami Miller School of Medicine 16. Non-Academic: Not Applicable. 17. Military: Not Applicable. PUBLICATIONS: 18. Books and Book Chapters:

1. Greenfield DS. Simultaneous stereoscopic optic disc photography. In: Schuman JS, ed., Imaging in glaucoma. Thorofare: SLACK Inc.; 1997:3-14.

2. Liebmann JM, Ritch R, Greenfield DS. The angle-closure glaucomas. In: Atlas of Glaucoma, edited by NT Choplin, Lundy DC. London: Martin Dunitz, 1998, pp. 133-153.

3. Greenfield DS. Ophthalmic imaging. In: Parrish RK, ed., Bascom Palmer Eye Institute’s Atlas of Ophthalmology. Philadelphia: Current Medicine, 1999:38-44.

4. Greenfield DS. Primary angle-closure glaucomas. In: Parrish RK, ed., Bascom Palmer Eye Institute's Atlas of Ophthalmology. Philadelphia: Current Medicine, 1999:198-202.

5. Greenfield DS and Fantes F. Secondary angle-closure glaucomas. In Parrish RK, ed., Bascom Palmer Eye Institute’s Atlas of Ophthalmology. Philadelphia: Current Medicine, 1999:202-6.

6. Flynn HW Jr., Kangas TA, Greenfield DS. Delayed-onset endophthalmitis associated with conjunctival blebs. In: Saer JB, ed., Proceedings of the 47th Annual Symposium of the New Orleans Academy of Ophthalmology. New Orleans: Kugler Publication, 1998: 177-85.

7. Greenfield DS. Non-pressure-dependent glaucoma. In: Lewis TL and Fingeret M, eds., Primary care of the glaucomas, New York:McGraw-Hill; 2001:493-506.

3

8. Greenfield DS. Optic nerve and retinal nerve fiber layer imaging in glaucoma. In: Ciulla T, Regillo C, Harris A, eds., Retina and Optic Nerve Imaging, Lippincott Williams & Wilkins.,2003:105-118.

9. Bagga H, Greenfield DS. Scanning laser polarimetry. In Huang D , Kaiser PK, Lowder CY, Traboulsi E, eds, Atlas of posterior segment imaging, Elsevier Inc., 2006:102-110.

10. Greenfield DS. Measuring neuroprotection in clinical trials. In: Weinreb RN, ed, Glaucoma: A review of new research in neuroprotection, Wolters Kluwer Health 2006:73-81.

11. Tello C, Liebmann JM, Ritch R, Greenfield DS. The angle closure glaucomas. In: Atlas of glaucoma, 2nd edn. London, UK: Informa healthcare, 2007: 149-168.

12. Quinn C and Greenfield DS. Choroidal effusion and hemorrhage. In: Glaucoma, edited by Shaarawy T, Sherwood MB, Hitchings R, and Crowston JG. London: Elsevier Inc., 2009: 195-205.

13. Greenfield DS. In which patients with glaucoma should I perform neuroimaging, cardiovascular, evaluation, and/or laboratory testing? In: Curbside Consultation in Glaucoma, edited by Heuer DH. New Jersey: Slack Inc., 2008:67-71.

14. Sheets C and Greenfield DS. Scanning laser polarimetry for glaucoma diagnosis and monitoring. In: Frequently asked questions in glaucoma, edited by Caprioli J, Giaconi J, Coleman A, and Law S. New York: Springer, 2010:35-43.

15. Greenfield DS and Liebmann JM. The RTVue in glaucomatous eyes. In: RTVue fourier-domain optical coherence tomography primer series, Volume III. Glaucoma. Edited by Weinreb RN and Varma R. California: Minuteman Printing Company, 2009:41-68.

16. Friedman D, Jonas J, Greenfield DS, Goldberg I. Drug Delivery. In: Medical Treatment of Glaucoma, edited by Weinreb RN and Liebmann JM. Amsterdam: Kugler Publications, 2010: 157-64.

17. Teng CT, Liebmann JM, Tello C, Ritch R, Greenfield DS. The angle closure glaucomas. In: Atlas of Glaucoma, Third Edition, edited by NT Choplin, Traverso CE. London: CRC Press, 2014:143-164.

18. Greenfield DS. In which patients with glaucoma should I perform neuroimaging, cardiovascular, evaluation, and/or laboratory testing? In: Curbside Consultation in Glaucoma, edited by Gedde SJ. New Jersey: Slack Inc, 2015:71-77.

19. Sheets C and Greenfield DS. Optic Nerve: Scanning laser polarimetry. In: Pearls of Glaucoma Management, edited by Giaconi J, Caprioli J, Coleman A, and Law S. New York: Springer, 2016 in press.

4

19. Juried or Refereed journal articles and exhibitions:

Original Reports:

1. Abramson DH, Greenfield DS, Ellsworth RM, et al. Neuron-specific enolase and

retinoblastoma: Clinicopathologic correlations. Retina 1989;9:148-52. 2. Abramson DH, Greenfield DS, Ellsworth RM, et al. Bilateral retinoblastoma: correlations between age at diagnosis and time course for new intraocular tumors. Ophthalmic Pediatrics and Genetics 1992;13:1-7.

3. Greenfield DS, Zacharia P, Schuman JS. Comparison of Nidek 3Dx and Donaldson simultaneous stereoscopic disc photography. Am J Ophthalmol 1993;116:741-7.

4. Greenfield DS, Bellows AR, Asdourian GK, et al. Iris retraction syndrome following intraocular surgery. Ophthalmology 1995;102:98-100. 5. Weiss JS, Weiss JN, Greenfield DS. The effect of Phenylephrine 2.5% vs. Phenylephrine 10% on pupillary dilation in diabetics, Retina 1995;15:130-3. 6. Greenfield DS, Jivanjee SQ, Raizman MB. Effect of corneal trephination on topography. Ophthalmic Surg and Lasers 1995;26:560-7.

7. Greenfield DS, Heggerick P,Hedges TR III. Color doppler imaging of normal orbital vasculature. Ophthalmology 1995;102:1598-1605.

8. Greenfield DS, Budenz DL, Curtin VT. Late visual loss secondary to filtering bleb exuberance. Arch Ophthalmol 1996;114:772-3. 9. Greenfield DS, Suner IJ, Miller MP, Kangas T, Flynn HW, Palmberg PF. Endophthalmitis after filtering surgery with mitomycin. Arch Ophthalmol 1996;114:943-9. 10.Greenfield DS, Miller MP, Suner IJ, Palmberg PF. Needle elevation of the scleral flap for failing filtration blebs after trabeculectomy with mitomycin C. Am J Ophthalmol 1996;122:195-204. 11. Suner IJ, Greenfield DS, Miller MP, Palmberg PF. Hypotony maculopathy following filtering surgery with mitomycin C. Ophthalmology 1997;104:207-15. 12. Kitizawa Y, Greenfield DS, Quigley HA, Werner, EB. Cases in controversy: Unilateral normal-tension glaucoma. J Glaucoma 1997;6:50-5. 13. Kangas TA, Greenfield DS, Flynn HW Jr. Delayed onset endophthalmitis associated with conjunctival filtering blebs. Ophthalmology 1997;104:746-52. 14. Greenfield DS, Wanichwecharungruang B, Liebmann JM, Ritch R. Pseudotumor cerebri appearing with unilateral papilledema after trabeculectomy. Arch Ophthalmol 1997;115:423-6. 15. Greenfield DS, Liebmann JM, Ritch R. Brimonidine: A new alpha2-adrenoreceptor agonist for glaucoma treatment. J of Glaucoma 1997;6:250-8. 16. Patelska B, Greenfield DS, Liebmann JM, Wand M, Kushnick H, Ritch R. Latanoprost for uncontrolled glaucoma in a compassionate case protocol. Am J Ophthalmol 1997;124:279-86. 17. Greenfield DS, Liebmann JM, Ritch R. Brimonidine: A new development in alpha2-

adrenoreceptor agonist therapy for patients with glaucoma. Semin Ophthalmol 1997;12:127-33.

5

18. Waheed S, Ritterband DC, Greenfield DS, Sidoti PA, Liebmann JM, Ritch R. Bleb- related ocular infection in children after trabeculectomy with mitomycin C. Ophthalmology 1997;104:2117-20.

19. Scott IU, Greenfield DS, Schiffman J, Palmberg PF. Outcomes of primary trabeculectomy with the use of adjunctive mitomycin. Arch Ophthalmol

1998;116:286-291. 20. Raviv T, Greenfield DS, Liebmann JM, Sidoti PA, Ritch R. Pericardial patch grafts in glaucoma implant surgery. J Glaucoma 1998;7:27-32. 21. Hoh ST, Ishikawa H, Greenfield DS, Liebmann JM, Ritch R. Scanning laser polarimetry: Reproducibility of peripapillary nerve fiber layer thickness measurements. J Glaucoma 1998;7:12-5. 22. Greenfield DS, Singh K, Whitcher JP, Mandelbaum S. Cases in controversy: Bleb-

related ocular infection. J Glaucoma 1998; 7:132-6. 23. Laroche D, McGowan B, Greenfield DS, Liebmann JM, Ritch R. Late Hypotony after Cataract Extraction Due to a Scleral Fistula. A Technique for Surgical Correction. Ophthalmic Surg and Lasers 1998;29:140-3. 24. Greenfield DS, Jee J, Liebmann JM, Ritch R. Late-onset bleb leaks after glaucoma filtering surgery. Arch Ophthalmol 1998;116:443-7. 25. Laroche D, Ishikawa H, Greenfield DS, Liebmann JM, Ritch R. Ultrasound biomicroscopic evaluation of anterior segment intraocular foreign bodies: Clinicopathologic correlations. Acta Ophthalmol Scan 1998;76:491-5. 26. Hoh ST, Greenfield DS, Ishikawa H, Liebmann JM, Chew SJ, Maw R, Ritch R. Factors affecting image acquisition during scanning laser polarimetry.

Ophthalmic Surg and Lasers 1998;29:545-51. 27. Waheed S, Liebmann JM, Greenfield DS, Ritterband DC, Seedor JA, Shah M,

Ritch R. Recurrent bleb infections. Br J Ophthalmol, 1998;82:926-9. 28. Gordon RN, Ritch R, Liebmann JM, Greenfield DS, Lama P. Lack of cross-reactive

response to brimonidine in patients with known apraclonidine allergy? Eye, 1998;12:697-700.

29. Greenfield DS, Siatkowski RM, Glaser JS, Schatz NJ, Parrish RK II. The cupped disc: Who needs neuroimaging? Ophthalmology, 1998:105:1866-74.

30. Breingan PJ, Esaki K, Ishikawa H, Liebmann JM, Greenfield DS, Ritch R. Iridolenticular contact distance decreases following laser iridotomy for pigment dispersion syndrome. Arch Ophthalmol, 1999;117:325-328.

31. Waheed S, Ritterband DC, Greenfield DS, Liebmann JM, Ritch R. New patterns of infecting organisms in late bleb-related endophthalmitis: A ten year review. Eye 1998; 12:910-5.

32. Greenfield DS. Glaucomatous vs. non-glaucomatous optic disc cupping: clinical differentation. Semin Ophthalmol 1999;14:95-108.

33. Greenfield DS, Tello C, Budenz DL, Liebmann JM, Ritch R. Aqueous misdirection after glaucoma drainage device implantation. Ophthalmology 1999;106:1035-40.

34. Hoh ST, Greenfield DS, Hillenkamp J, Liebmann JM, Ritch R. The effect of pupillary dilation on retinal nerve fiber layer measurement using scanning laser polarimetry. J Glaucoma 1999;8:159-163.

6

35. Altuna JC, Greenfield DS, Wand M, Liebmann JM, Camras C, Taglia DP, Kaufman PL, Cioffi GA, Lee DA, Robin AL, Crichton A, Costa VP, Ritch R. Latanoprost in glaucoma associated with Sturge-Weber Syndrome: benefits and side-effects. J

Glaucoma 1999;8:199-203. 36. Ozden RG, Ishikawa HI, Liebmann JM, Mistlberger A, Greenfield DS, Hoh ST,

Dou HL, Ritch R. Increasing sampling density improves optical coherence tomography measurement reproducibility. J Glaucoma, 1999;8:238-41.

37. Mistlberger A, Liebmann JM, Greenfield DS, Pons ME, Hoh ST, Ishikawa HI, Ritch R. Heidelberg retina tomography and optical coherence tomography in normal, ocular hypertensive and glaucomatous eyes. Ophthalmology 1999;106:2027-2032.

38. Greenfield DS. Optic nerve and retinal nerve fiber layer imaging in glaucomatous optic neuropathy. Int Ophthalmol Clin 1999;39:121-45.

39. Greenfield DS, Lerner SF, Lee B. Cases in controversy: Glaucoma associated with elevated episcleral venous pressure, J Glaucoma 2000;9:190-4.

40. Greenfield DS. Late complications of trabeculectomy. Ophthalmol Clin North America, 2000;13:531-43. 41. Åsman P, Fingeret M, Robin A,Wild J, Greenfield DS, Liebmann JM, Ritch R.

Influence of Kinetic vs. Static Fixation Targets on Fixation Accuracy in Automated Threshold Perimetry. J Glaucoma 1999;8:290-6

42. Hoh ST, Greenfield DS, Mistlberger A, Liebmann JM, Ishikawa H, Ritch R. Optical coherence tomography and scanning laser polarimetry in normal, ocular hypertensive, and glaucomatous eyes. Am J Ophthalmol 2000;129-35.

43. Soltau JB, Rothman RF, Budenz DL, Greenfield DS, Feuer W, Liebmann JM, Ritch R. Risk factors for glaucoma filtering bleb infections. Arch Ophthalmol 2000;118:338-42.

44. Marigo FA, Esaki K, Finger PT, Ishikawa H, Greenfield DS, Liebmann JM, Ritch R. Differential diagnosis of anterior segment cysts by ultrasound biomicroscopy, Ophthalmology 1999;106:2131-5.

45. Greenfield DS, Huang X-R, Knighton RW. The effect of corneal polarization axis upon retinal nerve fiber layer thickness assessment using scanning laser polarimetry, Am J Ophthalmol 2000;129:715-22.

46. Esaki K, Ishikawa H, Liebmann JM, Greenfield DS, Uji Y, Ritch R. Angle recess area decreases with age in normal Japanese. Jap J Ophthalmol 2000;44:46-51.

47. Greenfield DS, Parrish RK II. Detection of glaucomatous optic disc progression. Comp Ophthalmol Update 2000;1:87-96.

48. Scott IU, Gedde SJ, Budenz DL, Greenfield DS, Krishna R, Godfrey D. Baerveldt drainage implants in eyes with a preexisting scleral buckle. Arch Ophthalmol 2000;118:1509-13.

49. Singh K, Mehta K, Shaikh NM Tsai JC, Moster M, Budenz DL, Greenfield DS, Chen PP, Cohen JS, Baerveldt GS, Shaikh S, and the Primary Trabeculectomy Antimetabolite Study Group. Trabeculectomy with intraoperative mitomycin C versus 5-fluorouracil: prospective randomized clinical trial. Ophthalmology 2000;107:2305-9.

7

50. Greenfield DS. Dysfunctional glaucoma filtration blebs. Focal points: Clinical Modules for Ophthalmologists, American Academy of Ophthalmology June 2002;20:1-13.

51. Krishna R, Godfrey DG, Budenz DL, Escalona-Camaaño E, Gedde SJ, Greenfield DS, Feuer W, Scott IU. Intermediate-term outcomes of 350-mm2 Baerveldt glaucoma implants. Ophthalmology 2001;108:621-6.

52. Gedde SJ, Scott IU, Tabandeh H, Luu KKM, Budenz DL, Greenfield DS, Flynn HW Jr. Late endophthalmitis associated with glaucoma drainage implants. Ophthalmology 2001;108:1323-7.

53. Greenfield DS and Knighton RW. Stability of corneal polarization axis measurements for scanning laser polarimetry. Ophthalmology 2001;108:1065-9.

54. Godfrey DG, Krishna R, Greenfield DS, Budenz DL, Scott IU, Gedde SJ. Implanation of second glaucoma drainage devices after failure of primary devices. Ophthalmic Surg and Lasers 2002;33:37-43.

55. Knighton RW, Huang X-R, Greenfield DS. Analysis of scanning laser polarimetry for retinal nerve fiber layer assesment. Invest Ophthalmol Vis Sci 2002:43:383-92.

56. Greenfield DS. Optic nerve and retinal nerve fiber layer analyzers in glaucoma. Current Opinion in Ophthalmology 2002;13:68-76.

57. Mistlberger A, Liebmann JM, Greenfield DS, Hoh ST, Ishikawa H, Ritch R. Assessment of optic disc anatomy and nerve fiber layer thickness in ocular hypertensive subjects with normal short-wavelength automated perimetry. Ophthalmology 2002;109:1362-66.

58. Rhee DJ, Greenfield DS, Chen PP, Schiffman J. Reproducibility of retinal nerve fiber layer thickness measurements using scanning laser polarimetry in pseudophakic eyes. Ophthalmic Surg and Lasers 2002;33:117-22.

59. Greenfield DS, Knighton RW, Feuer W, Schiffman J, Zangwill L, Weinreb RN. Correction for corneal polarization axis improves the discriminating power of s

scanning laser polarimetry. Am J Ophthalmol 2002;134:27-33. 60. Villain MA, Greenfield DS. Peripapillary nerve fiber layer thickness measurement

reproducibility using optical coherence tomography. Ophthalmic Surg Lasers Imaging 2003;34:33-37.

61. Weinreb RN, Bowd C, Greenfield DS, Zangwill LM. Measurement of the magnitude and axis of corneal polarization with scanning laser polarimetry. Arch Ophthalmol, 2002:120:901-6.

62. Greenfield DS, Bagga H, Knighton RW. Macular thickness changes in glaucomatous optic neuropathy detected using optical coherence tomography. Arch Ophthalmol 2002;121:41-6.

63. Boehm MD, Nedrud C, Greenfield DS, Chen PP. Scanning laser polarimetry and detection of progression after optic disc hemorrhage in patients with glaucoma. Arch Ophthalmol 2003121:189-94.

64. Bagga H, Greenfield DS, Feuer W, Knighton RW. Scanning laser polarimetry with variable corneal compensation and optical coherence tomography in normal and glaucomatous eyes. Am J Ophthalmol 2003;135:521-9.

65. Bagga H, Greenfield DS, Knighton RW. Scanning laser polarimetry with variable corneal compensation: Identification and correction for corneal birefringence in eyes with macular pathology. Invest Ophthalmol Vis Sci 2003;44:1969-76.

8

66. Greenfield DS, Knighton RW, Schiffman J, Feuer W. Normative retardation data corrected for corneal polarization axis using scanning laser polarimetry. Ophthalmic Surg Lasers Imaging 2003;34:165-71.

67. Tannenbaum D, Hoffman D, Lemij HG, Garway-Heath DF, Greenfield DS, Caprioli J. Variable corneal compensation improves the discrimination between normal and glaucomatous eyes with the scanning laser polarimeter. Ophthalmology 2003;111:259-64.

68. Bagga H, Greenfield DS. Clinical assessment of the optic nerve and peripapillary retinal nerve fiber layer. Techniques in Ophthalmology 2003;1:98-105.

69. Bagga H, Greenfield DS. Quantitative assessment of structural damage in eyes with localized visual field abnormalities. Am J Ophthalmol 2004;137:797-805.

70. Bagga H, Greenfield DS. Retinal nerve fiber layer assessment using scanning laser polarimetry. International Ophthalmology Clinics 2004;44:29-42.

71. Schlottmann PG, De Cilla S, Greenfield DS, Caprioli J, Garway-Heath DF. Correlation of visual field sensitivity and retinal nerve fibre layer thickness as measured by scanning laser polarimetry. Invest Ophthalmol Vis Sci 2004; 45:1823-9.

72. Greenfield DS, Bagga H. Blood flow studies and serological testing in the diagnostic evaluation of glaucoma. A pilot study. Ophthalmic Surg Lasers Imaging 2004; 35: 406-14.

73. Huang X-R, Bagga H, Greenfield DS, Knighton RW. Variation of the peripapillary retinal nerve fiber layer birefringence in normal human subjects. Invest Ophthalmol Vis Sci 2004;45:3073-80.

74. Gunvant P, Zheng Y, Essock EA, Chen PP, Greenfield DS, Bagga H, Boehm MD. Predicting subsequent visual field loss in glaucomatous subjects with disc hemorrhage using RNFL polarimetry. J Glaucoma 2005;14:20-5.

75. Greenfield DS, Girkin C, Kwon Y. Memantine and progressive glaucoma. J Glaucoma 2005;14:84-6.

76. Bagga H, Greenfield DS, Feuer WJ. Quantitative assessment of atypical birefringence images using scanning laser polarimetry with variable corneal compensation. Am J Ophthalmol 2005;139:437-6.

77. Krupin T, Liebmann JM, Greenfield DS, Rosenberg LF, Ritch R, Yang JW, and the Low-pressure Glaucoma Study Group*The Low-pressure Glaucoma Treatment Study (LoGTS):Study Design and Baseline Characteristics of Enrolled Patients, Ophthalmology 2005;112:376-85.

78. Bagga H, Greenfield DS, and Knighton RW. Macular symmetry testing for glaucoma detection. J Glaucoma 2005;14:358-63.

79. Greenfield DS and Bagga H. Clinical variables associated with glaucomatous injury in eyes with large optic disc cupping. Ophthalmic Surg Lasers Imaging 2005;36:401-9.

80. Bagga H, Feuer WJ, Greenfield DS. Detection of psychophysical and structural injury in eyes with glaucomatous optic neuropathy and normal standard automated perimetry. Arch Ophthalmology 2006;124:169-76.

81. Sehi M, Guaqeta DC, Greenfield DS. An enhancement module to improve the atypical birefringence pattern using scanning laser polarimetry with variable corneal compensation. Br J Ophthalmol 2006;90:749-53.

9

82. Greenfield DS, Liebmann JM, Ritch R, Krupin T, and the Low-pressure Glaucoma Study Group. Visual Field and Intraocular Pressure Asymmetry in the Low-pressure Glaucoma Treatment Study (LoGTS). Ophthalmology 2007;114:460-5.

83. Budenz DL, Anderson DR, Varma R, Schuman JS, Cantor L, Savell J, Greenfield DS, Patella VM, Quigley HA, Tielsch J, Determinants of normal retinal nerve fiber layer thickness measured by STRATUS OCT. Ophthalmology 2007;114:1046-52.

84. Sehi M, Guaqueta DC, Feuer WJ, Greenfield DS, Advanced Imaging in Glaucoma Study Group. Scanning laser polarimetry with variable and enhanced corneal compensation in normal and glaucomatous eyes. Am J Ophthalmol 2007;143:272-79.

85. Sehi M, Guaqueta DC, Feuer WJ, and Greenfield DS. A comparison of structural measurements using two Stratus™ optical coherence tomography instruments. J Glaucoma 2007;16:287-92.

86. Sehi M, Ume S, Greenfield DS, and Advanced Imaging in Glaucoma Study Group. Scanning laser polarimetry with enhanced corneal compensation and optical coherence tomography in normal and glaucomatous eyes. Invest Ophthalmol Vis Sci 2007;48:2099-104.

87. Wellik, SR, Schiffman JC, Budenz DL, Greenfield DS. Relationship between central corneal thickness and hypotony-related complications after glaucoma surgery. Ophthalmic Surg Lasers Imaging 2008;39:281-7.

88. Lu ATH, Wang M, Varma R, Schuman JS, Greenfield DS, Smith SD, Huang D, and Advanced Imaging for Glaucoma Study Group. Combining nerve fiber layer parameters to optimize glaucoma diagnosis with optical coherence tomography. Ophthalmology 2008;115:1352-7.

89. Greenfield DS and Weinreb RN. Role of optic nerve imaging in glaucoma clinical practice and clinical trials. Am J Ophthalmol 2008;145:598-603.

90. Sehi M, Pinzon-Plazas M, Greenfield DS. Relationship between Pattern Electroretinogram, Standard Automated Perimetry, and Optic Nerve Structural Assessments. J Glaucoma 2009;18:608-17.

91. Grewal D, Sehi M, Greenfield DS. Diffuse Glaucomatous Structural and Functional Damage in the Hemifield Without Significant Pattern Loss. Arch Ophthalmol 2009;127(11):1442-48

92. Goodkin ML, Grewal DS, and Greenfield DS. Three-dimensional high-speed optical coherence tomography for diagnosis of hypotony maculopathy following glaucoma surgery. In Press, J Glaucoma.

93. Sehi M, Grewal D, Sheets C, Greenfield DS. Diagnostic ability of fourier-domain vs. time-domain optical coherence tomography for glaucoma detection. Am J Ophthalmol 2009;148:597-605.

94. Marsh BC, Cantor LB, WuDunn D, Hoop J, Lipyanik J, Patella VM, Budenz DL, Greenfield DS, Savell J, Schuman JS, Varma R. Generation of a normative database for optic nerve head (ONH) analysis by Stratus OCT™. In Press, J Glaucoma.

95. Radcliffe NM, Sehi M, Wallace IB, Greenfield DS, Krupin T, Ritch R. Comparison of stereo disc photos and alternation flicker using a novel matching technology for detecting glaucoma progression. Ophthalmic Surg Lasers Imaging 2010;41:629-34.

96. Grewal DS, Sehi M, Greenfield DS. Detecting glaucomatous progression using GDx with variable and enhanced corneal compensation using Guided Progression Analysis. Br J Ophthalmol 2011;95:502-8.

10

97. Sehi M, Grewal DS, Goodkin ML, Greenfield DS. Reversal of retinal ganglion cell dysfunction following surgical reduction of intraocular pressure. Ophthalmology, in press.

98. Grewal DS, Sehi M, Greenfield DS. Comparing rates of retinal nerve fiber layer loss with GDxECC using different methods of visual field progression. Br J Ophthalmol, in press.

99. Sehi M, Grewal DS, Feuer, WJ, Greenfield DS. The impact of intraocular pressure reduction on retinal ganglion cell function measured using pattern electroretinogram in eyes receiving latanoprost 0.005% versus placebo. Vision Research 2011;51:235-42.

100. Feuer WJ, Budenz DL, Anderson DR, Cantor L, Greenfield DS, Savell J, Schuman JS, Varma R. Topographic differences in the age related changes in the retinal nerve fiber layer of normal eyes measured by Stratus optical coherence tomography. J Glaucoma 2011;20:133-8.

101. Sehi M, Grewal DS, Zhu H, Feuer WJ, and Greenfield DS. Quantification of change in axonal birefringence following surgical reduction in IOP. Ophthalmic Surg Lasers Imaging 2011;42:45-52.

102. Krupin T, Liebmann JM, Greenfield DS, Ritch R, Gardiner S. A randomized double-masked trial of brimonidine versus timolol in preserving visual function: The Low-Pressure Glaucoma Treatment Study. Am J Ophthalmol 2011; 151:671-81.

103. Grewal DS, Sehi M, Paauw JD, Greenfield DS, and The Advanced Imaging for Glaucoma Study Group. Detection of progressive retinal nerve fiber layer thickness loss with optical coherence tomography using four criteria for functional progression. J Glaucoma 2012;21:214-20..

104. Grewal DS, Sehi M, Greenfield DS, and The Advanced Imaging for Glaucoma Study Group. The impact of retardance pattern variability on retinal nerve fiber layer measurements over time using scanning laser polarimetry with variable and enhanced corneal compensation. Invest Ophthalmol Vis Sci 2011;52:4516-24.

105. Girkin CA, Liebmann JM, Fingeret M, Greenfield DS, and Medeiros F. The effects of race, optic disc area, age, and disease severity on the diagnostic performance of spectral domain optical coherence tomography. Invest Ophthalmol Vis Sci 2011;52:6148-53.

106. Girkin CA, McGwin G, Sinai M, Sekhar GC, Fingeret M, Wollstein G, Varma R, Greenfield DS, Liebmann JM, Araie M, Tomita G, Maed N, and Garway-Heath DF. Variation in optic nerve and macular structure with age, race and ethnicity with spectral domain optical coherence tomography. Ophthalmology 2011;118:2403-8.

107. Hwang JC, Konduru R, Zhang X, Tan O, Francis B, Varma R, Sehi M, Greenfield DS, Sadda SR, and Huang D. Relationship among visual field, blood flow, and neural structure measurements in glaucoma. Invest Ophthalmol Vis Sci 2012;53:3020-6.

108. De Moraes CG, Sehi M, Greenfield DS, Chung YS, Ritch R, Liebmann JM. A validated risk calculator to assess risk and velocity of visual field progression in treated glaucoma patients. Invest Ophthalmol Vis Sci 2012;53:2702-7.

109. Bhardwaj N, Niles PI, Greenfield DS, Hymowitz M, Sehi M, Feuer WJ, and Budenz DL. The impact of surgical intraocular pressure reduction on visual function using various criteria to define progression. J Glaucoma 2013;22:632-7.

11

110. De Moraes CG, Liebmann JM, Greenfield DS, Gardiner SK, Ritch R, Krupin T. Risk factors for visual field progression in the Low-Pressure Glaucoma Treatment Study, Am J Ophthalmol 2012;154:702-11.

111. Niles PI, Greenfield DS, Sehi M, Chung YS, Advanced Imaging in Glaucoma Study Group. Detection of progressive macular thickness loss using optical coherence tomography in glaucoma suspect and glaucomatous eyes. Eye 2012;26:983-91.

112. Wang M, Tzu-Hui A, Varma R, Schuman JS, Greenfield DS, Huang D, and the Advanced Imaging for Glaucoma Study Group. Combining Information from Three Anatomic Regions in the Diagnosis of Glaucoma with Time-Domain Optical Coherence Tomography. J Glaucoma 2014;23:129–135.

113. Sehi M, Bhardwaj N, Chung YS, Greenfield DS, Advanced Imaging in Glaucoma Study Group. Evaluation of structural factors for predicting glaucomatous visual field progression using optical coherence tomography, scanning laser polarimetry, and confocal scanning laser ophthalmoscopy. Eye 2012;26:1527-35.

114. Sehi M, Zhang X, Greenfield DS, Chung YS, Wollstein G, Francis B, Schuman JS, Varma R, Huang D, on behalf of the Advanced Imaging in Glaucoma Study (AIGS) Group. Retinal nerve fiber layer atrophy is associated with visual field loss over time in glaucoma suspect and glaucomatous eyes. Am J Ophthalmol 2013;155:73-82.

115. Sehi M, Goharian I, Tan O, Srinivas S, Konduru R, Sadda S, Francis BA, Huang D, Greenfield DS. Retinal blood flow in glaucomatous eyes with single hemifield damage. Ophthalmology 2014;121:750-758.

116. Furlanetto RL, De Moraes CG, Teng CC, Liebmann JM, Greenfield DS, Gardiner SK, Ritch R, Krupin T. Risk factors for optic disc hemorrhage in the Low-pressure Glaucoma Treatment Study. Am J Ophthalmol 2014;157:945–952.

117. Iverson SM, Feuer WJ, Shi W, Greenfield DS. Frequency of abnormal retinal nerve fiber layer abnormalities in healthy eyes and glaucoma suspects in a prospective longitudinal study. Br J Ophthalmology 2014;98:920–925.

118. Meier KL, Greenfield DS, Rorer EM, Hilmantel G, Tarver ME, Lin C, Eydelman MB, Kahook MY, Singh K, Weinreb RN, Liebmann JM. Food and Drug Administration and American Glaucoma Society Sponsored Workshop: Validity, Reliability, and Usability of Glaucoma Imaging Devices, Ophthalmology 2014;121:216-23.

119. Martino AZ, Iverson S, Feuer WJ, Greenfield DS. Surgical outcomes of superior versus inferior glaucoma drainage device implantation. J Glaucoma 2015; 24:32–36.

120. Goharian I, Iverson SM, Ruiz RC, Kishor K, Greenfield DS, Sehi M. Reproducibility of retinal oxygen saturation in normal and treated glaucomatous eyes. Br J Ophthalmology 2015;99:318-22.

121. Loewen N, Zhang X, Tan O, Greenfield DS, Schuman JS, Varma, R, Huang D, and the Advanced Imaging for Glaucoma Study Group. Combining measurements from three anatomic areas for glaucoma diagnosis using fourier-domain optical coherence tomography. Br J Ophthalmol 2015;99:1224-9.

122. Iverson SM, Bhardwaj N, Shi W, Sehi M, Greenfield DS, Budenz DL, and Kishor K. Surgical outcomes of inflammatory glaucoma: A comparison of trabeculectomy and glaucoma drainage device implantation. Japanese Journal of Ophthalmology 2015;59:179-86.

12

123. Wright TW, Goharian I, Gardiner SK, Sehi M, Greenfield DS. Short-term Enhancement of Visual Field Sensitivity in Glaucomatous Eyes Following Surgical Intraocular Pressure Reduction. Am J Ophthalmol 2015; 159:378-85.

124. Iverson SM, Schultz SK, Shi W, Feuer WJ, Greenfield DS. Effectiveness of single digit IOP targets on decreasing global and localized visual field progression after filtration surgery in eyes with progressive normal tension glaucoma. J Glaucoma 2015 [Epub ahead of print] PMID: 25719235

125. Le PV, Zhang X, Francis FA, Varma R, Greenfield DS, Schuman JS, Loewen N, Huang D, Advanced Imaging for Glaucoma Study Group. Advanced Imaging for Glaucoma Study: Design, baseline characteristics, and inter-site comparison, Am J Ophthalmol 2015;159:393-403.

126. Iverson S, Spierer O, Papachristou GC, Feuer WJ, Shi W, Greenfield DS, O’Brien TP. Comparison of primary graft survival following penetrating keratoplasty and descemet’s stripping endothelial keratoplasty in eyes with prior trabeculectomy. Br J Ophthalmol 2015;99:1477-82.

127. Zhang X, Francis BA, Dastiridou A, Chopra V, Tan O, Varma R, Greenfield DS, Schuman JS, Huang D, for the Advanced Imaging for Glaucoma Study Group. Longitudinal and Cross-Sectional Analyses of Age Effects on Retinal Nerve Fiber Layer and Ganglion Cell Complex Thickness Measurements by Fourier-Domain OCT. Translational Vision Science & Technology, in press.

128. Zhang X, Loewen N, Tan O, Varma R, Greenfield DS, Schuman JS, Francis B, Huang D, for the Advanced Imaging for Glaucoma Study Group. Predicting development of glaucomatous visual field conversion using baseline fourier-domain optical coherence tomography. Am J Ophthalmol 2016;163:29-37.

129. Schultz SK, Iverson SM, Shi W, Greenfield DS. Safety and efficacy of achieving single digit intraocular pressure targets in eyes with progressive normal-tension glaucoma. J Glaucoma 2016;217-22

130. Richter GM, Zhang X, Francis BA, Chopra V, Greenfield DS, Varma R, Schuman JS, and Huang D. Regression analysis of optical coherence tomography disc variables for glaucoma diagnosis. J Glaucoma 2016 [Epub ahead of print] PMID: 26900833

13

Case Reports: 1. Greenfield DS, Siatkowski RM, Glaser JS, Schatz NJ. Bilateral lateral geniculitis associated with severe diarrhea. Am J Ophthalmol 1996;122:280-1. 2. Greenfield DS, Parrish RK. Airbag-related cyclodialysis cleft with angle closure

glaucoma. Ophthalmic Surg and Lasers 1996;27:955-7. 3. Greenfield DS, Parrish RK. Mitomycin filtering bleb rupture associated with crying Ophthalmic Surg and Lasers,1996;27:876-7. 4. Haddad A, Greenfield DS, Stegman Z, Liebman JM, Ritch R. Peters’ anomaly:

Diagnosis by ultrasound biomicroscopy. Ophthalmic Surg and Lasers 1997;28:311-2. 5. Greenfield DS, Liebmann JM, Ritch R. Spontaneous hyphema associated with exfoliation glaucoma and warfarin therapy. Am J Ophthalmol 1999;128:98-100. 6. Banta JT, Hoffman K, Budenz DL, Ceballos E, Greenfield DS. Topiramate- induced bilateral scute angle-closure glaucoma. Am J Ophthalmol 2001;132:112-

4. 7. Villain MA, Pageaux GP, Veurac M, Arnaud B, Harris A, Greenfield DS. Acute effect

of acetazolamide on ocular hemodynamics in pseudotumor cerebri associated with inflammatory bowel disease. Am J Ophthalmol 2002;134:778-80.

8. Sehi M, Greenfield DS. Assessment of peripapillary retinal nerve fiber layer using optical coherence tomography and scanning laser polarimetry with fixed and variable corneal compensation in progressive glaucomatous optic neuropathy. Am J Ophthalmol 2006;142:1056-9.

9. Sheets C, Grewal D, and Greenfield DS. Ocular toxoplasmosis presenting with focal retinal nerve fiber atrophy simulating glaucoma. J Glaucoma 2009;18:129-31.

Editorials: 1. Schuman JS and Greenfield DS. Ophthalmic Surgery Lasers and Imaging, the

Official Journal of the International Society for Imaging in the Eye. Ophthalmic Surg Lasers Imaging 2003;34:6.

2. Greenfield DS and Weinreb RN. Role of optic nerve imaging in glaucoma clinical practice and clinical trials. Am J Ophthalmol 2008;145:598-603.

3. Weinreb RN and Greenfield DS. A future for imaging technology in glaucoma. International Glaucoma Review 2008;10-3:104-5.

4. Leung C, Weinreb RN, Garway-Heath D, Greenfield DS, Medeiros F. New technologies for glaucoma imaging. Journal of Ophthalmology 2011. Hindawi Publishing Company,Volume 2011, Article ID 608975, 2 pages.

14

Letters to the Editor: 1. Greenfield DS, Heggerick P, Hedges TR III. Resistivity indices in CDI of ocular vessels (Author’s reply to letter to the editor). Ophthalmology 1996;103:1333-4. 2. Hoh ST, Greenfield DS, Ishikawa H, Liebmann JM, Chew SJ, Maw R, Ritch R. Factors affecting image acquisition during scanning laser polarimetry (Author’s

reply to letter to the editor). Ophthalmic Surg and Lasers 1999;30:411-2. 3. Greenfield DS, Siatkowski RM, Glaser JS, Schatz NJ, Parrish RK II. The cupped disc:

Who needs neuroimaging? Ophthalmology (Author’s reply to letter to the editor) 1999;106:855.

4. Greenfield DS, Huang X-R, Knighton RW. Effect of corneal polarization axis on assessment of retinal nerve fiber layer thickness by scanning laser polarimetry (Author’s reply to letter to the editor by Kogure and Iijima). Am J Ophthalmol 2001;131:403-4.

5. Greenfield DS, Huang W-R, Knighton RW. Effect of corneal polarization axis on assessment of retinal nerve fiber layer thickness by scanning laser polarimetry (Author’s reply to letter to the editor by Choplin). Am J Ophthalmol 2001;131:528-9.

6. Bagga H, Greenfield DS, and Knighton RW. Macular symmetry testing for glaucoma detection. (Author’s reply to letter to the editor by Zeimer). J Glaucoma 2006;15:182.

7. Greenfield DS, Liebmann JM, Krupin T, Ritch R. Visual field and intraocular pressure asymmetry in the Low-Pressure Glaucoma Treatment Study (Author’s reply to letter to the editor by Anderson DR). Ophthalmology 2008;115:590-2.

8. Krupin T, Liebmann JM, Ritch R, Greenfield DS, Gardiner S, LoGTS Group. The rate of progression and ocular perfusion pressure in the Low-Pressure Glaucoma Treatment Study (Author’s reply to letter to the editor by Quaranta L and Floriani I). Am Ophthalmol 2011;152:880-1.

9. Krupin T, Liebmann JM, Ritch R, Greenfield DS, Gardiner S, LoGTS Group. A randomized trial of brimonidine versus timolol in preserving visual function: The Low-Pressure Glaucoma Treatment Study (Author’s reply to letter to the editor by Garudadri CS et al) Am Ophthalmol 2011;152:877-8.

10. De Moraes CG, Liebmann JM, Ritch R, Greenfield DS, Sehi M. A validated risk calculator to assess risk and rate of visual field progression in treated glaucoma patients (Author’s reply to letter to the editor by Crabb D, Saunders L, and Russell R: The coefficient of determination – what determines a useful R2 statistic?) Invest Ophthalmol Vis Sci 2013:54:37-8.

11. Wright T, Goharian I, Gardiner SK, Sehi M, and Greenfield DS. Short-term Enhancement of Visual Field Sensitivity in Glaucomatous Eyes Following Surgical Intraocular Pressure Reduction. (Author’s reply to letters to the editor by Du Y, Goldberg I, Mansouri K, and Perera S) International Glaucoma Review 2015;16:28-32.

15

20. Other Works, Publications And Abstracts: Abstracts: 1. Abramson DH,Greenfield DS, Ellsworth RM, et al. Neuron-specific enlose in aqueous

of retinoblastoma and controls. Ophthalmology (Supplement) 1989;96:128. 2.Greenfield DS, Zacharia P, Schuman JS. Simultaneous stereoscopic disc photography:

Nidek 3Dx vs. Donaldson. Invest Ophthalmol Vis Sci (Supplement) 1993;34:1505.

3. Greenfield DS, Raizman MB. Effect of corneal trephination on topography Invest Ophthalmol Vis Sci (Supplement) 1994;35:1879.

4. Greenfield DS, Heggerick P, Hedges TR III. Color doppler imaging of normal orbital vasculature. Ophthalmology (Supplement) 1994;101:134.5.

5. Greenfield DS, Suner IJ, Miller MP, Palmberg PF. Endophthalmitis following filtering surgery with mitomycin C. Invest Ophthalmol Vis Sci (Supplement) 1995; 36:89.

6. Miller MP, Greenfield DS, Suner IJ, Palmberg PF. The outcome of bleb needling procedures after filtering surgery with mitomycin C. Invest Ophthalmol Vis Sci

(Supplement) 1995;36:344. 7. Kangas TA, Greenfield DS, Flynn HW. Delayed onset endophthalmitis associated with conjunctival filtering blebs. Invest Ophthalmol Vis Sci (Supplement) 1995;

36:631. 8. Suner IJ, Greenfield DS, Miller MP, Palmberg PF. Hypotony maculopathy following filtering surgery with mitomycin C: Incidence and treatment. Ophthalmology (Supplement) 1995;102:112.

9. Esaki K, Ishikawa H, Liebmann JM, Greenfield DS, Uji Y, Ritch R. Factors affecting angle configuration in Japanese. Invest Ophthalmol Vis Sci (Supplement)1997; 38:164.

10. Greenfield DS, Patelska B, Liebmann JM, Wand M, Kushnick H, Ritch R. Latanoprost for uncontrolled glaucoma. Invest Ophthalmol Vis Sci (Supplement) 1997; 38:281. 11. Gordon RN, Ritch R, Liebmann JM, Greenfield DS, Lama P. Alpha-agonist allergy:

Is there cross reactivity between apraclonidine and brimonidine? Invest Ophthalmol Vis Sci (Supplement) 1997; 38:559.

12. Hoh ST, Ishikawa H, Greenfield DS, Liebmann JM, Chew SJ, Ritch R. Scanning laser polarimetry: Reproducibility of peripapillary nerve fiber layer thickness measurements.Invest Ophthalmol Vis Sci (Supplement) 1997; 38:838. 13. Ishikawa H, Ritch R, Hoh ST, Liebmann JM, Greenfield DS, Uji Y. Iris volume before and after pupillary dilation using ultrasound biomicroscopy. Invest Ophthalmol Vis Sci (Supplement) 1997; 38:166. 14. Jee J, Greenfield DS, Liebmann JM, Patelska B, Ishikawa H, Ritch. Late-onset bleb

leaks after glaucoma filtering surgery. Invest Ophthalmol Vis Sci (Supplement) 1997; 38:1066.

15. Kruger E, Greenfield DS, Liebmann JM, Wand M, Kushnick H, Patelska B.Ritch R Latanoprost with adjunctive miotic therapy in a compassionate case protocol. Invest Ophthalmol Vis Sci (Supplement) 1997; 38:279.

16

16. Laroche D, Ishikawa H, Greenfield DS, Liebmann JM, Ritch R. Ultrasound biomicroscopic evaluation of anterior segment intraocular foreign bodies: Clinicopathologic correlations. Invest Ophthalmol Vis Sci (Supplement) 1997; 38:1070. 17. Maw R, Hoh ST, Greenfield DS, Ishikawa H, Liebmann JM, Chew SJ, Ritch R. Factors affecting image acquisition during scanning laser polarimetry. Invest Ophthalmol Vis Sci (Supplement) 1997; 38:838. 18. Raviv T, Greenfield DS, Liebmann JM, Sidoti PA, Ritch R. Pericardial patch grafts in glaucoma implant surgery. Invest Ophthalmol Vis Sci (Supplement) 1997; 38:272. 19. Ritterband DC, Waheed S, Greenfield DS, Liebmann JM, Shah MK, Seedor JA,

Ritch R. Recurrent Bleb infections. Invest Ophthalmol Vis Sci (Supplement) 1997; 38:1066.

20. Samson M, Ishikawa H, Hoh ST, Liebmann JM, Greenfield DS, Uji Y, Ritch R. The relationship between gain setting and quality of ultrasound biomicroscopic images. Invest Ophthalmol Vis Sci (Supplement) 1997;38:165.

21. Waheed S, Ritterband DC, Greenfield DS, Liebmann JM, Seedor JA, Ritch R. Late onset endophthalmitis associated with filtering blebs. Invest Ophthalmol Vis Sci Supplement) 1997; 38:1067. 22. Breingan P, Esaki K, Liebmann JM, Ishikawa H, Greenfield DS, Marigo FA, Uji U, Ritch R. Iridolenticular contact and angle recess area (ARA) decrease following laser iridotomy for pigment dispersion syndrome. Invest Ophthalmol Vis Sci (Supplement) 1998;39:472.

23. Greenfield DS, Mistlberger A, Hoh ST, Liebmann JM, Ishikawa H, Esaki K, Ritch R. Agreement between scanning laser polarimetry and achromatic automated perimetry using a neural network. Invest Ophthalmol Vis Sci (Supplement) 1998;39:702.

24. Ishikawa H, Hoh ST, Mistlberger A, Liebmann JM, Greenfield DS, Walsh J, Shabto U, Uji Y, Ritch R. Quantitative evaluation of intraretinal reflectivity with optical coherence tomography (OCT). Invest Ophthalmol Vis Sci (Supplement) 1998;39:106.

25. Hoh ST, Mistlberger A, Liebman JM, Greenfield DS, Ishikawa H, Ritch R. Reflectivitiy vs. retardation: Optical coherence tomography and scanning laser polarimetry. Invest Ophthalmol Vis Sci (Supplement) 1998;39:933.

26. Liebmann JM, Hoh ST, Mistlberger A, Ishikawa H, Greenfield DS, Ritch R. Increasing sampling density improves optical coherence tomography measurement reliability. Invest Ophthalmol Vis Sci (Supplement) 1998;39:933.

27. Rothstein R, Marigo FA, Esaki K, Ishikawa H, Liebmann JM, Finger P, Greenfield DS, Ritch R. Iridociliary neuroepithelial cysts. Invest Ophthalmol Vis Sci (Supplement) 1998;39:496.

17

28. Tello C, Greenfield DS, Budenz DL, Liebmann JM, Ritch R. Aqueous misdirection after glaucoma drainage device implantation. Invest Ophthalmol Vis Sci (Supplement) 1998;39:470.

29. Greenfield DS, Knighton RW, Huang X-R. Distribution of corneal polarization axes among normal eyes: Implications for scanning laser polarimetry. Invest Ophthalmol Vis Sci (Supplement) 1999;40:397.

30. Rhee D, Greenfield DS, Chen P, Schiffman J. Scanning laser polarimetry: reproducibility of peripapillary nerve fiber layer thickness measurements in pseudophakic eyes. Invest Ophthalmol Vis Sci (Supplement) 2000;41:287.

31. Greenfield DS, Knighton RW. Stability of corneal polarization axis measurements for scanning laser polarimetry. Invest Ophthalmol Vis Sci (Supplement) 2000;41:287. 32. McSoley J, Smith B, Greenfield DS, Budenz D, Feuer W, Anderson D. Sensitivity and specificity of white-on-white static threshold perimetry and frequency doubling technology in detection of glaucoma. Invest Ophthalmol Vis Sci (Supplement) 2000;41:104. 33. Gedde SJ, Scott IU, Budenz DL, Greenfield DS, Mello MO, Feuer W, Krishna R,

Godfrey D. Use of the Baerveldt implant in eyes with pre-existing episcleral encircling elements. Invest Ophthalmol Vis Sci (Supplement) 2000;41:579.

34. Villain MA, Greenfield DS, Knighton RW, Schiffman J, Feuer W. Normative retardation data corrected for corneal polarization axis using scanning laser polarimetry. Invest Ophthalmol Vis Sci (Supplement) 2001;42:135. 35. Knighton RW, Huang X-R, Greenfield DS. Linear birefringence measured in the

central cornea of a normal population. Invest Ophthalmol Vis Sci (Supplement) 2001;42:131.

36. Gedde SJ, Scott IU, Tabandeh H, Luu KKM Budenz DL, Greenfield DS. Late endophthalmitis associated with glaucoma drainage implants. Invest Ophthalmol Vis Sci (Supplement) 2001;42:249.

37. Greenfield DS, Knighton RW. Feuer W, Schiffman J, Zangwill L, Weinreb RN. Correction for corneal polarization axis improves discriminating power of scanning laser polarimetry. Invest Ophthalmol Vis Sci (Supplement) 2001;42:314.1

38. Garway-Heath DF, Bagga H, Greenfield DS, Caprioli J. Scanning laser polarimetry measurements of the retinal nerve fiber layer: Comparison of two strategies for correction of corneal birefringence. Invest Ophthalmol Vis Sci (Supplement) 2002.

39. Sohn YH, Banks M, Caprioli J, Garway-Heath DF, Bagga H, Greenfield DS. Optimal measurement parameters to distinguish between normal and glaucomatous eyes of the scanning laser polarimeter with fixed and variable corneal compensator settings. Invest Ophthalmol Vis Sci (Supplement) 2002.

40. De Cilla S, Bagga H, Greenfield DS, Caprioli J, Garway-Heath DF. The fixed and variable corneal compensator in scanning laser polarimetry: A comparison of normative data distribution and correlation with visual function. Invest Ophthalmol Vis Sci (Supplement) 2002.

41. Zangwill LM, Bowd C, Greenfield DS, Weinreb RN. Correction of corneal polarization axis and magnitude improves discriminating ability of GDx Nerve Fiber Analyzer (GDx). Invest Ophthalmol Vis Sci (Supplement) 2002.

18

42. Brockman M, Bagga H, Greenfield DS, Knighton RW. Scanning laser polarimetry with variable corneal compensation and optical coherence tomography in normal and glaucomatous eyes. Invest Ophthalmol Vis Sci (Supplement) 2002.

43. Greenfield DS, Bagga H, Knighton RW. Macular thickness changes in glaucomatous optic neuropathy detected using optical coherence tomography. Invest Ophthalmol Vis Sci (Supplement) 2002.

44. Bagga H, Greenfield DS, Knighton RW. Scanning laser polarimetry with variable corneal compensation in eyes with macular pathology. Invest Ophthalmol Vis Sci (Supplement) 2002.

45. Greenfield DS. Dose-response relationship of IOP to glaucoma progression. 2002 Annual Meeting Abstract Search and Program Planner (on CD-ROM). Association for Research in Vision and Ophthalmology, May 7, 2002, Abstract 1882.

46. Greenfield DS, Bagga H. The role of ancillary testing in the diagnostic evaluation of normal-tension glaucoma. 2003 Annual Meeting Abstract Search and Program Planner (on CD-ROM). Association for Research in Vision and Ophthalmology, May 6, 2003, Abstract 2153.

47. Garway-Heath DF, Greenfield DS, Caprioli J. Correlation of visual field sensitivity and retinal nerve fibre layer thickness as measured by scanning laser polarimetry. 2003 Annual Meeting Abstract Search and Program Planner (on CD-ROM). Association for Research in Vision and Ophthalmology, May 5, 2003, Abstract 980.

48. Bagga H, Greenfield DS, Knighton RW. The macular symmetry test for glaucoma detection. 2003 Annual Meeting Abstract Search and Program Planner (on CD-ROM). Association for Research in Vision and Ophthalmology, May 7, 2003, Abstract 3380.

49. Greenfield DS. Detection of progressive structural injury in glaucoma. 2003 Annual Meeting Abstract Search and Program Planner (on CD-ROM). Association for Research in Vision and Ophthalmology, May 6, 2003, Abstract 2046.

50. Gunvant P, Chen PP, Zheng Y, Greenfield DS, Bagga H, Boehm MD, Essock EA. Predicting Subsequent Visual Field Loss In Subjects With Disc Hemorrhage (DH) using RNFL Polarimetry, submitted for presentation at the 2003 annual meeting of the American Academy of Ophthalmology, Anaheim, CA.

51. Greenfield DS and Bagga H. Range of structural and functional abnormalities in eyes with advanced glaucomatous cupping; presented at the 2004 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL.

52. Mohammadi K, Bagga H, Greenfield DS. Prevalence of retinal nerve fiber layer and visual field abnormalities in eyes with pre-perimetric glaucomatous optic neuropathy using advanced imaging and psychophysical testing; presented at the 2004 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL.

53. Bagga H, Feuer W, Greenfield DS. Test-retest variability of scanning laser polarimetry with variable corneal compensation is not affected by severity of glaucomatous damage; presented at the 2004 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL.

19

54. Bagga H and Greenfield DS. Identification and correction of atypical birefringence

images using scanning laser polarimetry with variable corneal compensation; presented at the 2004 annual meeting of the International Society for Imaging in the Eye, Ft. Lauderdale, FL.

55. Knighton RW, Fredette MJ, Gregori G, Greenfield DS, Piovanetti O. The relation between ganglion cell layer thickness and visual sensitivity in the glaucomatous human macula; presented at the 2005 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL.

56. Greenfield DS, Liebmann JM, Ritch R, Krupin T, and The Low-pressure Glaucoma Study Group. Relationship of Intraocular Pressure and Visual Field Damage in the Low-pressure Glaucoma Treatment Study; presented at the 2005 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL.

57. Ishikawa H, Wollstein G, Gabriele ML, Bonfioli AA, Dilworth B, Noecker R, Greenfield DS, Mattox C, Varma R, Schuman JS. Signal Strength Outperformed Signal To Noise Ratio In Evaluating Stratus OCT Image Quality; presented at the 2005 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL

58. Liebmann JM,Greenfield DS, Ritch R, Krupin T, and The Low-pressure Glaucoma Study Group. Baseline intraocular pressure, visual function, and disc hemorrhage in the Low-Pressure Glaucoma Treatment Study; presented at the 2005 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL

59. Fraser-Bell S, Varma R, Lipyanik J, Patella VM, Budenz DL, Cantor L, Greenfield DS, Savell J, Schuman JS, and Ying-Lai M.Age, Gender, Ethnicity and Refractive error related differences in normal macular thickness and volume as measured by STRATUS OCT; presented at the 2005 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL

60. Wagner SH, DelBono E, Greenfield DS, Parrish RK, Haines JL, Wiggs JL. A second locus for pigment dispersion syndrome maps to chromosome 18q21; presented at the 2005 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL.

61. Wellik SR, Budenz DL, Greenfield DS. Relationship between central corneal thickness and hypotony-related complications after glaucoma surgery; presented at the 2006 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL.

62. Sehi M, Guaqueta DC, Feuer WJ, Greenfield DS, Advanced Imaging in Glaucoma Study Group. An enhancement module to improve the atypical birefringence pattern using scanning laser polarimetry with variable corneal compensation; presented at the 2006 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL.

63. Ishikawa H, Wollstein G, Noecker RJ, Greenfield DS, Mattox C, Varma R, Bilonick RA, Schuman JS. Optical coherence tomography quality evaluation revisited with common classification criteria; presented at the 2006 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL.

20

64. Marsh BC, Cantor LB, WuDunn D, Lipyanik J, Patella M, Budenz DL, Greenfield DS, Savell J, Schuman J, Varma R. Generation of a normative database for optic nerve head analysis by Stratus OCT; presented at the 2006 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL.

65. Guaqueta DC, Sehi M, Feuer WJ, Greenfield DS. A comparison of structural measurements using two Stratus™ optical coherence tomography instruments; presented at the 2006 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL.

66. Ume SC, Sehi M, Feuer WJ, Greenfield DS, Advanced Imaging in Glaucoma Study Group. Structural assessments using scanning laser polarimetry with enhanced corneal compensation, optical coherence tomography, and Heidelberg retina tomography in normal and glaucomatous eyes; presented at the 2006 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL.

67. Kishor K, Pinzon-Plazas M, Sehi M, Greenfield DS. Repeatability of steady-state pattern electroretinogram in normals, glaucoma suspects, and glaucomatous eyes; presented May 6 at the 2007 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL.

68. Sehi M, Pinzon-Plazas M, Greenfield DS. Relationship between retinal ganglion cell function, nerve fiber layer thickness, and optic nerve head topography; presented May 6 at the 2007 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL.

69. Pinzon-Plazas M, Sehi M, Kishor K, Greenfield DS. Assessment of glaucomatous visual field progression identified using three progression criteria; presented May 7 at the 2007 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL.

70. Sheets C, Grewal DS, Sehi M, Greenfield DS. Comparison of time-domain and spectral-domain optical coherence tomography for glaucoma diagnosis; presented April 30 at the 2008 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL.

71. Sehi M, Grewal DS, Greenfield DS. Effect of intraocular pressure reduction on optic nerve topography and retinal nerve fiber layer thickness; presented April 29 at the 2008 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL.

72. Grewal DS, Sehi M, Greenfield DS. Diffuse retinal nerve fiber layer atrophy exists in eyes with localized glaucomatous visual field deficits; presented April 28 at the 2008 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL.

73. Sinai MJ, Garway-Heath DF, Schlottmann PG, Greenfield DS, Sehi M, Fingeret M, Varma R, Liebmann JM, Huang D. The effect of age, optic disc size, signal strength, and sample size on RTVue fourier domain OCT normal measurements of the RNFL, Optic Disc, And Ganglion Cell Complex; presented April 30 at the 2008 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL.

74. Sehi M, Grewal DS, Shi W, Feuer WJ, Greenfield DS. Quantification of change in axonal birefringence following surgical reduction in IOP; presented March 6th at the 2009 annual meeting of the American Glaucoma Society, San Diego, CA.

21

75. Sehi M, Grewal DS, Shi W, Feuer WJ, Greenfield DS. Axonal birefringence changes following surgical reduction in IOP; presented May 6 at the 2009 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL.

76. Fingeret M, Sinai MJ, Garway-Heath DF, Greenfield DS, Varma R, Liebmann JM, Schuman J, Girkin C. and the Optovue Normative Database Study Group. The normal thickness of the ganglion cell complex in the macula measured with Fourier domain OCT; presented May 5 at the 2009 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL.

77. Goodkin ML, Grewal DS, Sehi, Greenfield DS. Retinal ganglion cell response to IOP reduction following glaucoma surgery; presented May 4 at the 2009 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL.

78. Grewal DS, Sehi M, Greenfield DS, and the Advanced Imaging in Glaucoma Study Group. Detecting glaucomatous progression using scanning laser polarimetry with variable and enhanced corneal compensation; presented May 4 at the 2009 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL.

79. Kishor K, Grewal DS, Sehi M, Quinn CD, Greenfield DS, and the Advanced Imaging in Glaucoma Study Group. Detecting glaucomatous progression using structural and functional measures; presented May 4 at the 2009 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL.

80. Radcliffe NM, Sehi M, Wallace IB, Greenfield DS, Krupin T, Ritch R. Comparison of stereo disc photos and alternation flicker using a novel matching technology for deteting glaucomatous changes in the optic disc; presented May 4 at the 2009 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL.

81. Sinai MJ, Garway-Heath DF, Greenfield DS, Fingeret M, Varma R, Liebmann JM, Schuman J, Girkin C. and the Optovue Normative Database Study Group. The role of ethnicity on the retinal nerve fiber layer and optic disc area measured with Fourier domain optical coherence tomography; presented May 4 at the 2009 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL.

82. Radcliffe NM, Sehi M, Wallace IB, Greenfield DS, Krupin T, Ritch R. Comparison of stereo disc photos and alternation flicker using a novel matching technology for deteting glaucomatous changes in the optic disc; presented at the 2009 World Glaucoma Congress, Boston, MA.

83. Grewal D, Goodkin ML, and Greenfield DS. Three-dimensional high-speed optical coherence tomography for diagnosis of hypotony maculopathy following glaucoma surgery; presented at the 2009 World Glaucoma Congress, Boston, MA.

84. Grewal D, Sehi M, Greenfield DS. Detection of Progressive Retinal Nerve Fiber Layer Thickness Loss Using Scanning Laser Polarimetry with Enhanced Corneal Compensation Using Various Criteria for Functional Progression; presented March 6th at the 2010 annual meeting of the American Glaucoma Society, Naples, FL.

85. Sehi M, Grewal D, Goodkin M, Greenfield DS. Reversal of Retinal Ganglion Cell Dysfunction Following Surgical Reduction of Intraocular Pressure; presented March 5th at the 2010 annual meeting of the American Glaucoma Society, Naples, FL.

22

86. Kishor K, Grewal D, Sehi M, Greenfield DS, and Advanced Imaging in Glaucoma Study Group. Longitudinal detection of progressive optic disc change in glaucoma suspects and glaucomatous eyes; presented at the 2010 annual meeting of the Association for Research in Vision and Ophthalmology, Fort Lauderdale, FL.

87. Paauw J, Grewal D, Sehi M, Greenfield DS, and Advanced Imaging in Glaucoma Study Group. Detection of progressive retinal nerve fiber layer thickness loss with optical coherence tomography using various criteria for functional progression; presented at the 2010 annual meeting of the Association for Research in Vision and Ophthalmology, Fort Lauderdale, FL.

88. Grewal D, Sehi M, Greenfield DS. The impact of retardance pattern stability on retinal nerve fiber layer thickness measurements over time using scanning laser polarimetry with variable and enhanced corneal compensation; presented at the 2010 annual meeting of the Association for Research in Vision and Ophthalmology, Fort Lauderdale, FL.

89. Sehi M, Grewal D, Greenfield DS. The impact of intraocular pressure reduction on retinal ganglion cell function using pattern electroretinogram in eyes receiving latanoprost 0.005% versus placebo; presented at the 2010 annual meeting of the Association for Research in Vision and Ophthalmology, Fort Lauderdale, FL.

90. Sehi M, Grewal D, Goodkin ML, Greenfield DS. Reversal of retinal ganglion cell dysfunction following glaucoma surgery; presented April 30th at the 2010 annual Vision Research Conference (VRES), Fort Lauderdale, FL.

91. De Moraes CG, Sehi M, Chung YS, Greenfield DS, Ritch R, Liebmann JM. Prediction of risk and rates of visual field progression in patients with established, treated glaucoma; presented March 4th at the 2011 annual meeting of the American Glaucoma society, Dana Point, CA.

92. Sehi M, Bhardwaj N, Reyes MC, Chung YS, Greenfield DS. Baseline optic nerve topography and retinal nerve fiber layer thickness predicts progression in glaucoma suspect and glaucomatous eyes; presented March 5th at the 2011 annual meeting of the American Glaucoma society, Dana Point, CA.

93. Krupin T, Liebmann JM, Greenfield DS, Ritch R, Gardiner S. A randomized trial of brimonidine versus timolol in preserving visual function: Results from the Low-Pressure Glaucoma Treatment Study; presented March 4th at the 2011 annual meeting of the American Glaucoma society, Dana Point, CA.

94. Lee RK, Loo DA, Hodgson LG, Wong TY, Greenfield DS, Crowston JG. Optic nerve head vessel caliber changes in glaucoma; presented March 5th at the 2011 annual meeting of the American Glaucoma society, Dana Point, CA.

95. Huang D, Zhang XTO, Konduru R, Hwang JC, Sadda SR, Francis BA, Varma R, Sehi M, Greenfield DS. Correlation between retinal blood flow, retinal anatomy, and visual field in glaucoma; presented April 30, 2011 at the 2011 annual meeting of the Association for Research in Vision and Ophthalmology/ISIE meeting, Ft. Lauderdale, FL.

96. Sehi M, Reyes MC, Konduru R, Tan O, Huang D, Greenfield DS. Retinal blood flow in glaucomatous eyes with single-hemifield damage; presented April 30, 2011 at the 2011 annual meeting of the Association for Research in Vision and Ophthalmology/ISIE meeting, Ft. Lauderdale, FL.

23

97. Erickson J, Reyes M, Shi W, Bhardwaj N, Sehi M, and Greenfield DS. The effect of cataract grade and location on quality of ocular imaging scans; presented May 1st at the 2011 annual meeting of the Association for Research in Vision and Ophthalmology, Fort Lauderdale, FL.

98. Niles PI, Sehi M, Bhardwaj N, Greenfield DS, and Advanced Imaging in Glaucoma Study Group. Detection of progressive macular thickness loss using optical coherence tomography in glaucoma suspect and glaucomatous eyes; presented May 2nd at the 2011 annual meeting of the Association for Research in Vision and Ophthalmology, Fort Lauderdale, FL.

99. Bhardwaj N, Sehi M, Shi W, Greenfield DS, and Advanced Imaging in Glaucoma Study Group. Macular ganglion cell thickness measurements using Fourier-Domain OCT for prediction of glaucomatous progression; presented May 4th at the 2011 annual meeting of the Association for Research in Vision and Ophthalmology, Fort Lauderdale, FL.

100. Sehi M, Bhardwaj N, Reyes MC, Chung YS, and Greenfield DS. Baseline structural measures predict functional progression in glaucoma; presented May 4th at the 2011 annual meeting of the Association for Research in Vision and Ophthalmology, Fort Lauderdale, FL.

101. Huang D, Zhang TO, Konduru R, Hwang JC, Sadda SR, Francis BA, Varma R, Sehi M, and Greenfield DS. Correlation between retinal blood flow, retinal anatomy, and visual field in glaucoma; presented April 30, 2011 at the 2011 annual meeting of the Association for Research in Vision and Ophthalmology/ISIE meeting, Ft. Lauderdale, FL.

102. Lee RK, Loo DA, Hodgson LG, Wong TY, Greenfield DS, Crowston JG. Optic nerve head vessel caliber changes in glaucoma; presented October 27th at the 2011 annual meeting of the Palm Beach County Medical Society, Palm Beach, FL.

103. Huang D, Hwang JC, Konduru R, Zhang X, Tan O, Francis BA, Varma R, Sehi M, Greenfield DS, Sadda SR. Relationship among visual field, blood flow, and neural structure measurements in glaucoma; presented March 2nd at the 2012 annual meeting of the American Glaucoma Society, New York, New York.

104. De Moraes CG, Liebmann JM, Greenfield DS, Gardiner SK, Ritch R, Krupin T. Risk factors for visual field progression in the Low-Pressure Glaucoma Treatment Study; presented March 2nd at the 2012 annual meeting of the American Glaucoma Society, New York, New York.

105. Sehi M, Chung YS, Greenfield DS, Zhang X, Wollstein G, Schuman JS, Varma R, Huang D, and the Advanced Imaging in Glaucoma Study Group. Retinal nerve fiber layer loss is associated with visual field loss over time in glaucoma suspect and glaucomtaous eyes; presented March 2nd at the 2012 annual meeting of the American Glaucoma Society, New York, New York.

106. Teng CC, De Moraes CG, Liebmann JM, Greenfield DS, Gardiner SK, Ritch R, and Krupin T for the LoGTS Investigators. Risk factors for optic disc hemorrhage in the Low-pressure Glaucoma Treatment Study; presented at the 2012 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL.

107. Shah M, Zhang X, Varma R, Greenfield DS, Schuman JS, Huang D, AIGS Group. Baseline nerve fiber layer and ganglion cell complex thickness by optical coherence tomography as risk factors for the development of glaucomatous visual

24

field defects; presented at the 2012 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL.

108. Bhardwaj N, Niles PI, Greenfield DS, Hymowitz MB, Sehi M, Feuer WJ, Budenz DL. The impact of surgical intraocular pressure reduction on vsual function using various criteria to define visual field progression; presented at the 2012 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL.

109. Martino AZ, Iverson SM, Feuer WJ, Greenfield DS. Surgical outcomes of superior versus inferior glaucoma drainage device implantation; presented at the 2012 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL.

110. Huang D, Zhang X, Varma R, Greenfield DS, Schuman JS, and the Advanced Imaging for Glaucoma Study Group. Nerve fiber layer and ganglion cell complex measurements by optical coherence tomography as risk factors for visual field progression in glaucoma; presented at the 2012 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL.

111. Iverson SM, Sehi M, Harvey B, Greenfield DS, and the Advanced Imaging for Glaucoma Study (AIGS) Group. Evaluation of optic disc progression in glaucoma using spectral domain optical coherence tomography; presented at the 2012 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL.

112. Goharian I, Greenfield DS, Sehi M. Cluster-based trend analysis of visual field progression in low-tension and high-tension open-angle glaucoma; presented at the 2013 annual meeting of the Association for Research in Vision and Ophthalmology, Seattle, WA.

113. Iverson SM, Sehi M, Feuer WJ, Greenfield DS, and the Advanced Imaging for Glaucoma Study (AIGS) Group. Frequency of abnormal retinal nerve fiber layer and ganglion cell layer SDOCT scans in healthy eyes and glaucoma suspects; presented at the 2013 annual meeting of the Association for Research in Vision and Ophthalmology, Seattle, WA.

114. Papchristou GC, Greenfield DS, O’Brien TP, Schiffman J, Shi W, Iverson S. Comparison of graft survival following penetrating keratoplasty and descemet’s stripping endothelial keratoplasty in medically and surgically treated glaucoma patients; presented at the 2013 annual meeting of the Association for Research in Vision and Ophthalmology, Seattle, WA.

115. Schultz SK, Iverson SM, Shi W, Schiffman JC, Greenfield DS. Long-term outcomes of filtration surgery for normal-tension glaucoma with visual field progression at low intraocular pressure; presented at the 2013 annual meeting of the Association for Research in Vision and Ophthalmology, Seattle, WA.

116. Sehi M, Goharian I, Konduru R, Tan O, Srinivas S, Sadda S, Huang D, Greenfield DS. Reduced retinal blood flow is associated with thinner retinal nerve fiber layer in glaucomatous eyes with single hemifield damage; presented at the 2013 annual meeting of the Association for Research in Vision and Ophthalmology, Seattle, WA.

117. Teng CC, DeMoraes CG, Liebmann JM, Greenfield DS, Ritch R, Krupin T, for the LoGTS Investigators. Central corneal thickness and IOP response to topical

25

ocular hypotensive medication in the Low-pressure Glaucoma Treatment Study; presented at the 2013 annual meeting of the Association for Research in Vision and Ophthalmology, Seattle, WA.

118. Tan O, Zhang X, Loewen N, Schuman J, Greenfield DS, Varma R, Huang D, and the AIGS Group. The effect of image quality on the reliability of nerve fiber layer measurements with fourier-domain OCT; presented at the 2013 annual meeting of the Association for Research in Vision and Ophthalmology, Seattle, WA.

119. Schultz SK, Greenfield DS, Iverson SM, Shi W. Achieving single digit IOP control with filtration surgery in eyes with progressive normal-tension glaucoma; presented at the 2014 annual meeting of the American Glaucoma Society, Washington DC.

120. Maharaj A, Greenfield DS, Iverson SM, Goharian I, Sehi M, Zhang X, Huang D, Schuman JS, Varma R, Francis BA. Progressive retinal nerve fiber layer atrophy is associated with reduced central corneal thickness in glaucoma suspect and glaucomatous eyes; presented at the 2014 annual meeting of the American Glaucoma Society, Washington DC.

121. Iverson SM, Schultz SK, Shi W, Feuer WJ, Greenfield DS. Effectiveness of achieving single digit IOP targets with filtration surgery on decreasing global and localized visual field progression in eyes with progressive normal-tension glaucoma; presented at the 2014 annual meeting of the Association for Research in Vision and Ophthalmology, Orlando, FL.

122. Chan J, De Moraes CG, Weinreb RN, Greenfield DS, Krupin T, Gardiner SK, Liebmann JM, Ritch R, for the Low-Pressure Glaucoma Treatment Study Group. Baseline visual field damage as a predictor of faster rates of visual field progression in the Low-pressure Glaucoma Treatment Study; presented at the 2014 annual meeting of the Association for Research in Vision and Ophthalmology, Orlando, FL.

123. Goharian I, Iverson SM, Ruiz RC, Kishor K, Greenfield DS, Sehi M. Retinal oxygen saturation in treated glaucomatous eyes; presented at the 2014 annual meeting of the Association for Research in Vision and Ophthalmology, Orlando, FL.

124. Maharaj AS, Sehi M, Greenfield DS, Iverson SM, Goharian I, Zhang X, Francis BA, Schuman JS, Varma R, Huang D. Progressive retinal nerve fiber layer atrophy is associated with thin central corneal thickness in glaucoma suspect and glaucomatous eyes; presented at the 2014 annual meeting of the Association for Research in Vision and Ophthalmology, Orlando, FL.

125. Sehi M, Greenfield DS, Kishor K, Ruiz RC, Srinivas S, Iverson SM, Goharian I. Relationship between retinal blood flow, ganglion cell function, and retinal oxygenation in glaucomatous and normal eyes; presented at the 2014 annual meeting of the Association for Research in Vision and Ophthalmology, Orlando, FL.

126. Wright T, Goharian I, Gardiner SK, Greenfield DS, Sehi M. Enhancement of visual field sensitivity in glaucomatous eyes following surgical intraocular pressure reduction; presented at the 2014 annual meeting of the Association for Research in Vision and Ophthalmology, Orlando, FL.

127. De Moraes CG, Liebmann JM, Greenfield DS, Ritch R, and Krupin T. Reliability indices, sensitivity loss, and rates of visual field change in glaucoma; presented at the 2014 annual meeting of the Association for Research in Vision and Ophthalmology, Orlando, FL.

26

128. Huang D, Zhang X, Loewen N, Tan O, Francis B, Varma R, Greenfield DS, and Schuman J. Predicting Glaucomatous Visual Field Damage with Fourier- Domain Optical Coherence Tomography in the Advanced Imaging for Glaucoma Study; presented at the 2014 annual meeting of the American Academy of Ophthalmology, Chicago, IL.

129. Zhang X, Francis B, Tan O, Varma R, Greenfield DS, Schuman JS, Loewen NA, Sehi M, Huang D. Longitudinal and cross-secional analyses of age and intraocular pressure effects on retinal nerve fiber layer and ganglion cell complex thickness; presented at the 2015 annual meeting of the American Glaucoma Society, Coronado, CA.

130. Goharian I, Shaw J, Gardiner SK, Wright TM, Greenfield DS. Long-term evaluation of visual field enhancement in glaucomatous eyes following surgical intraocular pressure reduction; presented at the 2015 annual meeting of the Association for Research in Vision and Ophthalmology, Denver, CO.

131. Wright TM, Goharian I, Feuer WJ, Shi W, Greenfield DS. Three-year outcomes of glaucoma drainage device surgery in eyes with and without prior conjunctival incisional surgery; presented at the 2015 annual meeting of the Association for Research in Vision and Ophthalmology, Denver, CO.

CD Rom: 1. Greenfield DS. Simultaneous stereoscopic optic disc photography. In: Schuman JS, ed., Imaging in Glaucoma: The 1996 Boston Glaucoma Course. 2. Greenfield DS. Ophthalmic imaging. In: Parrish RK, ed., Bascom Palmer Eye

Institute’s Atlas of Ophthalmology. 3. Palmberg PF and Greenfield DS. Primary angle-closure glaucomas. In: Parrish RK,

ed., Bascom Palmer Eye Institute's Atlas of Ophthalmology. 4. Greenfield DS and Fantes F. Secondary angle-closure glaucomas. In Parrish RK, ed.,

Bascom Palmer Eye Institute’s Atlas of Ophthalmology.

27

Audio Tape: 1. Greenfield DS and Mills RP. Normal-tension glaucoma: Making the diagnosis. In: EyeNet Audio, American Academy of Ophthalmology, April 2000 Volume II, No. 4. 2. Greenfield DS. Cupping with low IOP. In: Audio-Digest 1999; Volume 37: Issue 16. 3. Greenfield DS. Quantitative assessment of the retinal nerve fiber layer. Co-regulation

of intraocular pressure and blood flow in glaucoma. In: Audio-Digest 2001; Volume 39: Issue 25.

21. Other Works submitted for publication:

1. Wroblewski D, Zhang X, Schuman JS, Greenfield DS, Francis BA, Varma R, Huang D, for the Advanced Imaging for Glaucoma Study Group. Image resampling and empirical noise model for quantitative assessment of visual field progression. Am J Ophthalmol, submitted.

2. Zhang X, Dastiridou A, Francis BA, Tan O, Varma R, Greenfield DS, Schuman JS, Sehi M, Chopra V, Huang D, On behalf of the Advanced Imaging for Glaucoma Study Group. Baseline Fourier-Domain OCT Structural risk factors for visual field progression in the advanced imaging for glaucoma study. Am J Ophthalmol, submitted.

28

PROFESSIONAL: 22. Funded Research: 1994 - 1995: $10,000 Clinical research grant, The Heed Ophthalmic Foundation, Cleveland,

OH. 1994 - 1995: $10,000 Clinical research grant, The Heed-Knapp Ophthalmic Foundation, Cleveland, OH. 1996: Clinical research grant, the Sturge-Weber Foundation. 1996 - 1997: Co-investigator: Ocular Hypertension Treatment Study (OHTS), New York City

Study Center, funded by the NIH (Jeffrey Liebmann, Principal Investigator). 1996 - 1997: Co-investigator: Collaborative Initial Glaucoma Treatment Study (CIGTS), New

York City Study Center, funded by the NIH (Robert Ritch, Principal Investigator). 1999 – 2005: Principal Investigator (David S. Greenfield, M.D.): A 60-month, multicentered,

randomized, double-masked, placebo-controlled clinical study to evaluate the effectiveness and safety of oral memantine (192944-OAG) in patients with chronic open-angle glaucoma, funded by Allergan, Inc., $412,090

1999 - 2005: Principal Investigator (David S. Greenfield, M.D.): A multicenter, double-masked, 2-arm parallel group study comparing the effect of brimonidine 0.2% versus timolol 0.5% on visual field stability in patients with normal-tension glaucoma, funded by an unrestricted grant by the Low-Pressure Glaucoma Research Group, $18,000.

1999 – 2003: Co-Investigator: Retinal Nerve Fiber Layer Reflectance Mechanisms, National Institutes of Health grant R01 EY08684 (Robert W. Knighton, Ph.D., Principal Investigator), $679,000. 2001: Principal Investigator (David S. Greenfield, M.D.): Evaluation of corneal

compensation in scanning laser polarimetry measurement of the retinal nerve fiber layer thickness, funded by Laser Diagnostic Technologies, $20,000.

2003-2006: Co-Investigator: Prospective randomized controlled clinical trial comparing topical medical therapy vs. selective laser trabeculoplasty, funded by Lumenis, $20,000, (Donald L. Budenz, M.D., Principal Investigator).

2003 - 2008: Co-Investigator: Retinal Nerve Fiber Layer Reflectance Mechanisms, National Institutes of Health grant R01 EY08684 (Robert W. Knighton, Ph.D., Principal Investigator), $1,250,000

2003 - 2013: Principal Investigator, BPEI study site: Advanced Imaging for Glaucoma, National Institutes of Health grant RO1 EY013516 (David Huang, M.D., Principal Investigator), $1,250,000.

2006 – 2010: Principal Investigator: Relationship between Intraocular Pressure Fluctuation and Retinal Ganglion Cell Function in Eyes Receiving Latanoprost 0.005% versus Placebo, funded by Pfizer Inc ($120,000).

2007 – 2010: Principal Investigator: Retinal ganglion cell response to intraocular pressure reduction following glaucoma surgery, funded by Allergan Inc ($100,000).

2007 – 2009: Principal Investigator: Collection of normative and glaucomatous data for RTVue, funded by Optovue Inc ($12,000).

2012 – 2013: Principal Investigator: Evaluation of structural progression in glaucoma using spectral domain optical coherence tomography, funded by The Eyebank for Sight Restoration, New York, NY, $50,000.

29

2016 – 2021: Principal Investigator, BPEI study site: Lessening the Impact in Glaucoma from Hypertension (LIGHT). National Institutes of Health grant UG1 submission (Jeffrey Liebmann MD, Principal Investigator) $1,561,428.

23. Editorial Responsibilities:

Associate Editor, Ophthalmic Surg Lasers Imaging (2002 – 2014) Editorial Board, Journal of Glaucoma (2005 – Present) Editorial Board, American Journal of Ophthalmology (2006 – Present) Executive Editor, American Journal of Ophthalmology (2016 – Present)

Editorial Board, International Glaucoma Review 24. Professional and Honorary Organizations: 1986 - Present: American Medical Association 1991 - Present: Fellow, American Academy of Ophthalmology 1992 - Present: Association for Research in Vision and Ophthalmology 1994 - Present: American Society of Cataract and Refractive Surgery 1994 - Present: Society of Heed Fellows 1996 - 2000: North American Neuro-Ophthalmology Society 1996 - 1999: New York Glaucoma Society 1996 - 1999: New York Society for Clinical Ophthalmology 1996 - 1999: New York State Ophthalmological Society

1997 - 1999: Ophthalmic Laser Surgical Society 1998 - Present: Palm Beach Ophthalmological Society 1998 - Present: Miami Ophthalmological Society 1999 - Present: Fellow, American College of Surgeons 2000 - Present: Active Member, American Glaucoma Society (President-Elect 2013-3014) 2002 - 2007: Co-founder & Secretary-Treasurer, International Society for Imaging in the Eye 2009 – Present: Co-founder & Executive Vice-President: Florida Glaucoma Society

30

25. Honors and Awards: American Academy of Ophthalmology 36th Robert N. Shaffer Lecturer, 2015 American Academy of Ophthalmology Senior Achievement Award, 2011 American Glaucoma Society Physician-Scientist Lecturer, 2010 American Academy of Ophthalmology Achievement Award, 2003 Tenure, University of Miami, 2002 Top-Ten 2001 ARVO glaucoma paper, “Correction for corneal polarization axis improves the diagnostic precision of scanning laser polarimetry”, International Glaucoma Review Top-Ten 2000 glaucoma publication, “The effect of corneal polarization axis on assessment of retinal nerve fiber layer thickness by scanning laser polarimetry”, International Glaucoma Review Glaucoma Service Award, The Glaucoma Foundation, 1997 Heed Ophthalmic Foundation, 1994-5. Winner, Annual Paper Competition, Florida Society of Ophthalmology, 1995 Charles J. Preefer Award for Academic Excellence, 1993 Alpha Omega Alpha, 1989 Phi Beta Kappa, 1986 Magna Cum Laude, 1986 New York University Founders Day Award, 1986 Gross Anatomy Teaching Fellow, 1986 Beta Lambda Sigma - Biology Honor Society, 1986 26. Post-Doctorial Fellowships: 1995: Clinical Fellow, Neuro-Ophthalmology, Bascom Palmer Eye Institute University of Miami School of Medicine, Miami, FL 1995: Heed-Knapp Fellow, Neuro-Ophthalmology, Bascom Palmer Eye Institute, University of Miami School of Medicine, Miami, FL 1994 - 1995: Clinical Fellow, Glaucoma, Bascom Palmer Eye Institute, University of Miami School of Medicine, Miami, FL 1994 - 1995: Heed Fellow, Glaucoma, Bascom Palmer Eye Institute, University of Miami School of Medicine, Miami, FL 27. Other Professional Activities:

Scientific Presentations: 1. Abramson DH, Greenfield DS, Ellsworth RM, et al.: Neuron-specific

enolase in aqueous of retinoblastoma and controls; presented at the 1989 annual meeting of the American Academy of Ophthalmology, New Orleans, Louisiana.

2. Abramson DH, Greenfield DS, Ellsworth RM, et al.: Bilateral retinoblastoma: correlations between age at diagnosis and time course for new intraocular tumors; presented at the 1990 annual meeting of the

International Society for Genetic Eye Diseases / V International Symposium on Retinoblastoma, Atlanta, Georgia.

31

3. Greenfield DS, Zacharia P, Schuman JS: Simultaneous Stereodisk Photography: Nidek 3Dx vs. Donaldson; presented at the 1993 annual meeting of the Association for Research in Vision and Ophthalmology, Sarasota, Fl.

4. Greenfield DS, Zacharia P, Schuman JS: Simultaneous Stereodisk Photography: Nidek 3Dx vs. Donaldson; presented at the 1994 annual meeting of the

International Congress of Ophthalmology, International Conference on Ophthalmic Photography, Toronto, Ontario, Canada.

5. Greenfield DS, Jivanjee SQ, Raizman MB: Effect of Corneal Trephination on Topography; presented at the 1994 annual meeting of the Association for Research in Vision and Ophthalmology, Sarasota, Fl.

6. Greenfield DS, Heggerick P, Hedges TR III: Color Doppler Imaging of normal orbital vasculature: presented at the 1994 annual meeting of the American Academy of Ophthalmology, San Francisco, Ca.

7. Greenfield DS, Heggerick P, Hedges TR III: Color Doppler Imaging of normal orbital vasculature: presented at the 1995 annual meeting of the North American Neuro Ophthalmology Society, Tucson, AZ.

8. Kangas T, Greenfield DS, Flynn HW Jr.: Delayed onset endophthalmitis associated with conjunctival filtering blebs: presented at the 1995 annual meeting of the

vitreous Society, London, England. 9. Greenfield DS, Miller MP, Palmberg PF: Endophthalmitis following filtering surgery

with mitomycin C: presented at the 1995 annual meeting of the Association for Research in Vision and Ophthalmology, Fort Lauderdale, Fl.

10. Greenfield DS, Miller MP, Palmberg PF: Endophthalmitis following filtering surgery with mitomycin C: presented at the 1995 annual meeting of the Florida

Society of Ophthalmology, Naples, Fl. 11. Miller MP, Greenfield DS, Palmberg PF: The outcome of bleb needling procedures after filtering surgery with mitomycin C: presented at the 1995 annual meeting of

the Association for Research in Vision and Ophthalmology, Sarasota, 12. Kangas TA, Greenfield DS, Flynn HW Jr: Delayed onset endophthalmitis associated with conjunctival filtering blebs: presented at the 1995 annual meeting of the

Association for Research in Vision and Ophthalmology, Ft. Lauderdale, Fl. 13. Suner IJ, Greenfield DS, Miller MP, Palmberg PF. Hypotony maculopathy following filtering surgery with mitomycin C: Incidence and Outcome: presented

at the 1995 annual meeting of the American Academy of Ophthalmology, Atlanta, Ga. 14. Esaki K, Ishikawa H, Liebmann JM, Greenfield DS, Uji Y, Ritch R. Factors affecting angle configuration in Japanese: presented at the 1997 annual meeting of

the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, Fl. 15. Greenfield DS, Patelska B, Liebmann JM, Wand M, Kushnick H, Ritch R.

Latanoprost for uncontrolled glaucoma: presented at the 1997 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, Fl.

16. Gordon RN, Ritch R, Liebmann JM, Greenfield DS, Lama P. Alpha-agonist allergy: Is there cross reactivity between apraclonidine and brimonidine? Presented at the

1997 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, Fl.

32

17. Hoh ST, Ishikawa H, Greenfield DS, Liebmann JM, Chew SJ, Ritch R. Scanning laser polarimetry: Reproducibility of peripapillary nerve fiber layer thickness

measurements: presented at the 1997 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, Fl. 18. Ishikawa H, Ritch R, Hoh ST, Liebmann JM, Greenfield DS, Uji Y. Iris volume

before and after pupillary dilation using ultrasound biomicroscopy: presented at the 1997 annual meeting of the Association for Research in Vision and

Ophthalmology, Ft. Lauderdale, Fl. 19. Jee J, Greenfield DS, Liebmann JM, Patelska B, Ishikawa H, Ritch. Late-onset bleb leaks after glaucoma filtering surgery: presented at the 1997 annual meeting of the

Association for Research in Vision and Ophthalmology, Ft. Lauderdale, Fl. 20. Kruger E, Greenfield DS, Liebmann JM, Wand M, Kushnick H, Patelska B, Ritch R. Latanoprost with adjunctive miotic therapy in a compassionate case protocol:

presented at the 1997 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, Fl.

21. Laroche D, Ishikawa H, Greenfield DS, Liebmann JM, Ritch R. Ultrasound biomicroscopic evaluation of anterior segment intraocular foreign bodies:

Clinicopathologic correlations: presented at the 1997 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, Fl. 22. Maw R, Hoh ST, Greenfield DS, Ishikawa H, Liebmann JM, Chew SJ, Ritch R.

Factors affecting image acquisition during scanning laser polarimetry: presented at the 1997 annual meeting of the Association for Research in Vision and

Ophthalmology, Ft. Lauderdale, Fl 23. Raviv T, Greenfield DS, Liebmann JM, Sidoti PA, Ritch R. Pericardial patch grafts in glaucoma implant surgery: presented at the 1997 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, Fl. 24. Ritterband DC, Waheed S, Greenfield DS, Liebmann JM, Shah MK, Seedor JA, Ritch R. Recurrent Bleb infections: presented at the 1997 annual meeting of the

Association for Research in Vision and Ophthalmology, Ft. Lauderdale, Fl. 25. Samson M, Ishikawa H, Hoh ST, Liebmann JM, Greenfield DS, Uji Y, Ritch R. The

relationship between gain setting and quality of ultrasound biomicroscopic images: presented at the 1997 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, Fl.

26. Waheed S, Ritterband DC, Greenfield DS, Liebmann JM, Seedor JA, Ritch R. Late- onset endophthalmitis associated with filtering blebs: presented at the 1997 annual

meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, Fl. 27. Greenfield DS, Siatkowki RM, Glaser JS, Schatz NJ, Parrish RK II. Glaucomatous

vs. non-glaucomatous optic nerve cupping: clinical and psychophysical correlations. Presented at the 1997 annual meeting of the American

Academy of Ophthalmology, San Francisco, CA. 28. Heneghan CJ, Liebman JM, Greenfield DS, Sidoti PA, Ritch R. Determination of

clinical guidelines for digital imaging of the anterior segment for application in teleophthalmology. Presented at the 1997 annual meeting of the American Academy of Ophthalmology, San Francisco, CA.

33

29. Rothman R, Marcus CH, Greenfield DS, Liebmann JM, Prywes AS, Ritch R. Latanoprost as alternative or additional treatment for glaucoma. Presented at the 1997 annual meeting of the American Academy of Ophthalmology, San Francisco, CA.

30. Greenfield DS, Glaucoma associated with Sturge Weber Syndrome: presented at annual Sturge-Weber Foundation conference, Parsippany, NJ, 8-97.

31. ⊕Asman P, Fingeret M, Robin A,Wild J, Greenfield DS, Liebmann JM, Ritch R. Influence of Kinetic vs. Static Fixation Targets on Fixation Accuracy in Automated Threshold Perimetry. Presented at The North American Perimetric Society (NAPS) 7-97.

32. Greenfield DS, Harris A, Fingeret M. Ocular blood flow abnormalities in glaucoma, The 1997 annual meeting of The American Academy of Optometry, San Antonio,

Tx, December 11-13th. 33. Hoh ST, Greenfield DS, Hillenkamp, J, Liebmann JM, Ritch R. The effect of

pupillary dilation on retinal nerve fiber layer measurement using scanning laser polarimetry. Presented at the 1997 meeting of the American Glaucoma Society, Scottsdale, AZ.

34. Breingan P, Esaki K, Liebmann JM, Ishikawa H, Greenfield DS, Marigo, FA, Uji U, Ritch R. Iridolenticular contact and angle recess area (ARA) decrease following laser iridotomy for pigment dispersion syndrome: presented at the 1998 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, Fl. 35. Greenfield DS, Mistlberger A, Hoh ST, Liebmann JM, Ishikawa H, Esaki K, Ritch R. Agreement between scanning laser polarimetry and achromatic automated perimetry using a neural network: presented at the 1998 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, Fl.

36. Ishikawa H, Hoh ST, Mistlberger A, Liebmann JM, Greenfield DS, Walsh J, Shabto U, Uji Y, Ritch R. Quantitative evaluation of intraretinal reflectivity with optical coherence tomography (OCT): presented at the 1998 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, Fl.

37. Hoh ST, Mistlberger A, Liebman JM, Greenfield DS, Ishikawa H, Ritch R. Reflectivity vs. retardation: Optical coherence tomography and scanning laser polarimetry: presented at the 1998 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, Fl.

38. Liebman JM, Hoh ST, Mistlberger A, Ishikawa H, Greenfield DS, Ritch R. Increasing sampling density improves optical coherence tomography measurement reliability: presented at the 1998 annual meeting of the Association

for Research in Vision and Ophthalmology, Ft. Lauderdale, Fl. 39. Rothstein R, Marigo FA, Esaki, Ishikawa H, Liebman JM, Finger P,

Greenfield DS, Ritch R. Iridociliary neuroepithelial cysts: presented at the 1998 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, Fl.

40. Tello C, Greenfield DS, Budenz DL, Liebman JM, Ritch R. Aqueous misdirection after glaucoma drainage device implantation: presented at the 1998

annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, Fl.

34

41. Greenfield DS, Knighton RW, Huang X-R. Distribution of corneal polarization axes among normal eyes: Implications for scanning laser polarimetry: presented at the 1999 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, Fl.

42. Godfrey DG, Krishna R, Greenfield DS, Budenz DL, Gedde SJ, Scott IU, Parrish RK II. Implantation of second glaucoma drainage devices after failure of primary devices: presented at the 2000 annual meeting of the American Glaucoma Society, San Antonio, TX

43. Gedde SJ, Scott IU, Budenz DL, Greenfield DS, Mello MO, Feuer W, Krishna R, Godfrey D. Use of the Baerveldt implant in eyes with pre-existing episcleral encircling elements: presented at the 2000 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, Fl.

44. McSoley J, Smith B, Greenfield DS, Budenz D, Feuer W, Anderson D. Sensitivity and specificity of white-on-white static threshold perimetry and frequency doubling technology in detection of glaucoma: presented at the 2000 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, Fl.

45. Greenfield DS, Knighton RW. Stability of corneal polarization axis measurements for scanning laser polarimetry: presented at the 2000 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, Fl.

46. Rhee D, Greenfield DS, Chen P, Schiffman J. Scanning laser polarimetry: reproducibility of peripapillary nerve fiber layer thickness measurements in pseudophakic eyes: presented at the 2000 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, Fl. 47.Gedde SJ, Scott IU, Budenz DL, Greenfield DS, Flynn HW Jr., Feuer WJ, Krishna R, Godfrey DG, Mello MO Jr. Baerveldt drainage implants in eyes with a pre- existing scleral buckle: presented at the 2000 annual meeting of the American Academy of Ophthalmology, Dallas, TX. 48. Greenfield DS, Knighton RW. Stability of corneal polarization axis measurements

for scanning laser polarimetry: presented at the 2001 annual meeting of the International Glaucoma Society, Prague, Czech Republic, March, 2001.

49. Greenfield DS, Knighton RW, Feuer W, Schiffman J, Zangwill L, Weinreb RN. Correction for corneal polarization axis improves discriminating power of scanning laser polarimetry: presented at the 2001 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, Fl.

50. Villain MA, Greenfield DS, Knighton RW, Schiffman J, Feuer W. Normative retardation data corrected for corneal polarization axis using scanning laser polarimetry: presented at the 2001 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, Fl.

51. Knighton RW, Huang X-R, Greenfield DS. Linear birefringence measured in the central cornea of a normal population: presented at the 2001 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, Fl.

52. Gedde SJ, Scott IU, Tabandeh H, Luu KKM Budenz DL, Greenfield DS. Late endophthalmitis associated with glaucoma drainage implants: presented at the 2001 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, Fl.

35

53. Greenfield DS. Automated Detection of Glaucomatous Structural Change- Are we there yet? Glaucoma 2001 Subspecialty Day Program, New Orleans, LA, 11-01.

54. Greenfield DS. Dose-response relationship of IOP to glaucoma progression: presented at the 2002 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL.

55. Zangwill LM, Bowd C, Greenfield DS, Weinreb RN. Correction of corneal polarization axis and magnitude improves discriminating ability of GDx Nerve Fiber Analyzer (GDx): presented at the 2002 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL.

56. Greenfield DS, Bagga H, Knighton RW. Macular thickness changes in glaucomatous optic neuropathy detected using optical coherence tomography: presented at the 2002 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL.

57. Greenfield DS. Scanning laser polarimetry with custom corneal compensation: an update: presented at the 2002 annual meeting of the Association for Research in Vision and Ophthalmology, Special Interest Group, Retinal Imaging, Ft. Lauderdale, FL.

58. Greenfield DS. Discussion of “Topical application of autologous serum to treat aqueous oozing or point-leak through filtering bleb” (Tomidokoro et al): presented at the 2002 annual meeting of the American Academy of Ophthalmology, Orlando, FL, 10-02.

59. Krupin T, Ritch R, Liebmann JM, Greenfield DS, Yang JW, and the low-tension research group. Low tension glaucoma treatment study (LoGTS): Baseline clinical characteristics. Presented at the 2003 annual meeting of the International Congress of Ophthalmology, Paris, Fr, 3-03.

60. Greenfield DS. Detection of progressive structural injury in glaucoma: presented at the 2003 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL.

61. Greenfield DS, Bagga H. The role of ancillary testing in the diagnostic evaluation of normal-tension glaucoma: presented at the 2003 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL.

62. Garway-Heath DF, Greenfield DS, Caprioli J. Correlation of visual field sensitivity and retinal nerve fibre layer thickness as measured by scanning laser polarimetry: presented at the 2003 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL.

63. Bagga H, Greenfield DS. Quantitative assessment of structural damage in eyes with localized visual field abnormalities using optical coherence tomography and scanning laser polarimetry: presented at the 2003 annual meeting of the International Society for Imaging in the Eye, Ft. Lauderdale, FL.

64. Gunvant P, Zheng Y, Essock EA, Chen PP, Greenfield DS, Bagga H, Boehm MD. Predicting subsequent visual field loss in subjects with disc hemorrhage using RNFL polarimetry: presented at the 2003 annual meeting of the American Academy of Optometry, Dallas, TX, Dec, 2003.

65. Greenfield DS and Bagga H. Range of structural and functional abnormalities in eyes with advanced glaucomatous cupping; presented at the 2004 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL.

36

66. Mohammadi K, Bagga H, Greenfield DS. Prevalence of retinal nerve fiber layer and visual field abnormalities in eyes with pre-perimetric glaucomatous optic neuropathy using advanced imaging and psychophysical testing; presented at the 2004 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL.

67. Bagga H, Feuer W, Greenfield DS. Test-retest variability of scanning laser polarimetry with variable corneal compensation is not affected by severity of glaucomatous damage; presented at the 2004 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL.

68. Bagga H and Greenfield DS. Identification and correction of atypical birefringence images using scanning laser polarimetry with variable corneal compensation; presented at the 2004 annual meeting of the International Society for Imaging in the Eye, Ft. Lauderdale, FL.



71. Ishikawa H, Wollstein G, Gabriele ML, Bonfioli AA, Dilworth B, Noecker R, Greenfield DS, Mattox C, Varma R, Schuman JS. Signal Strength Outperformed Signal To Noise Ratio In Evaluating StratusOCT Image Quality; presented at the 2005 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL

72. Liebmann JM,Greenfield DS, Ritch R, Krupin T, and The Low-pressure Glaucoma Study Group. Baseline intraocular pressure, visual function, and disc hemorrhage in the Low-Pressure Glaucoma Treatment Study; presented at the 2005 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL

73. Fraser-Bell S, Varma R, Lipyanik J, Patella VM, Budenz DL, Cantor L, Greenfield DS, Savell J, Schuman JS, and Ying-Lai M.Age, Gender, Ethnicity and Refractive error related differences in normal macular thickness and volume as measured by STRATUS OCT; presented at the 2005 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL.

74. Wellik SR, Budenz DL, Greenfield DS. Relationship between central corneal thickness and hypotony-related complications after glaucoma surgery; presented at the 2006 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL.

75. Sehi M, Guaqueta DC, Feuer WJ, Greenfield DS, Advanced Imaging in Glaucoma Study Group. An enhancement module to improve the atypical birefringence pattern using scanning laser polarimetry with variable corneal compensation; presented at the 2006 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL.

76. Ishikawa H, Wollstein G, Noecker RJ, Greenfield DS, Mattox C, Varma R, Bilonick RA, Schuman JS. Optical coherence tomography quality evaluation revisited with

37

common classification criteria; presented at the 2006 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL.

77. Marsh BC, Cantor LB, WuDunn D, Lipyanik J, Patella M, Budenz DL, Greenfield DS, Savell J, Schuman J, Varma R. Generation of a normative database for optic nerve head analysis by Stratus OCT; presented at the 2006 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL.

78. Guaqueta DC, Sehi M, Feuer WJ, Greenfield DS. A comparison of structural measurements using two Stratus™ optical coherence tomography instruments; presented at the 2006 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL.

79. Ume SC, Sehi M, Feuer WJ, Greenfield DS, Advanced Imaging in Glaucoma Study Group. Structural assessments using scanning laser polarimetry with enhanced corneal compensation, optical coherence tomography, and Heidelberg retina tomography in normal and glaucomatous eyes; presented at the 2006 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL.

80. Guaqueta DC, Sehi M, Feuer W, Greenfield DS. A comparison of macula and optic nerve head structural measurements using two Stratus™ Optical Coherence Tomography (OCT) Instruments; presented at the 2006 annual meeting of the International Society for Imaging in the Eye, Ft. Lauderdale, FL.

81. Greenfield DS. Glaucoma diagnosis by optic disc evaluation; presented at the 2006 World Ophthalmology Congress, International Congress of Ophthalmology, Sau Paulo, Brazil.

82. Greenfield DS. How do I treat ocular hypertension in the presence of non-glaucomatous optic neuropathy; presented at the 2006 glaucoma subspecialty day symposium at the annual meeting of the American Academy of Ophthalmology, Las Vegas, NV.

83. Kishor K, Pinzon-Plazas M, Sehi M, Greenfield DS. Repeatability of steady-state pattern electroretinogram in normals, glaucoma suspects, and glaucomatous eyes; presented May 6 at the 2007 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL.

84. Sehi M, Pinzon-Plazas M, Greenfield DS. Relationship between retinal ganglion cell function, nerve fiber layer thickness, and optic nerve head topography; presented May 6 at the 2007 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL.

85. Pinzon-Plazas M, Sehi M, Kishor K, Greenfield DS. Assessment of glaucomatous visual field progression identified using three progression criteria; presented May 7 at the 2007 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL.

86. Detection of Structural Glaucomatous Progression, presented March 28th, 2007 at the 6th annual meeting of the International Glaucoma Symposium, Athens, Greece.

87. Beyond IOP lowering: The Low-Pressure Glaucoma Treatment Study; presented March 29, 2007 at the 6th annual meeting of the International Glaucoma Symposium, Athens, Greece.

88. Greenfield DS. Glaucoma diagnosis using imaging, presented at the 2007 glaucoma subspecialty day symposium at the annual meeting of the American Academy of Ophthalmology, New Orleans, LA.

89. Sheets C, Grewal DS, Sehi M, Greenfield DS. Comparison of time-domain and spectral-domain optical coherence tomography for glaucoma diagnosis; presented April 30 at the 2008

38

annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL.

90. Sehi M, Grewal DS, Greenfield DS. Effect of intraocular pressure reduction on optic nerve topography and retinal nerve fiber layer thickness; presented April 29 at the 2008 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL.

91. Grewal DS, Sehi M, Greenfield DS. Diffuse retinal nerve fiber layer atrophy exists in eyes with localized glaucomatous visual field deficits; presented April 28 at the 2008 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL.

92. Sinai MJ, Garway-Heath DF, Schlottmann PG, Greenfield DS, Sehi M, Fingeret M, Varma R, Liebmann JM, Huang D. The effect of age, optic disc size, signal strength, and sample size on RTVue fourier domain OCT normal measurements of the RNFL, Optic Disc, And Ganglion Cell Complex; presented April 30 at the 2008 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL.

93. Greenfield DS. Normal-tension glaucoma: Clinical challenges and new therapeutic concepts; presented May 22 at the 2008 annual meeting of the International Perimetry Society, Nara, Japan.

94. Sehi M, Grewal DS, Shi W, Feuer WJ, Greenfield DS. Quantification of change in axonal birefringence following surgical reduction in intraocular pressure. presented March 6th at the 2009 annual meeting of the American Glaucoma Society, San Diego, CA.

95. Fingeret M, Sinai MJ, Garway-Heath DF, Greenfield DS, Varma R, Liebmann J, Schuman JS, Girkin C, Optovue Normative Database Study Group. The normal thickness of the ganglion cell complex in the macula measured with Fourier Domain OCT. Presented May 5 at the 2009 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL.

96. Goodkin ML, Grewal DS, Sehi M, Greenfield DS. Retinal ganglion cell response to IOP reduction following glaucoma surgery. Presented May 4 at the 2009 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL.

97. Grewal DS, Sehi M, Greenfield DS, Advanced Imaging in Glaucoma Study Group. Detecting glaucomatous progression using scanning laser polarimetry with variable and enhanced corneal compensation. Presented May 4 at the 2009 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL.

98. Kishor K, Grewal DS, Sehi M, Quinn CD, Greenfield DS. Detecting glaucomatous progression using structural and functional measures. Presented May 4 at the 2009 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL.

99. Radcliffe NM, Sehi M, Wallace IB, Greenfield DS, Krupin T, Ritch R. Comparison of stereo disc photos and alternation flicker using a novel matching technology for detecting glaucomatous changes in the optic disc. Presented May 4 at the 2009 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL.

100. Sehi M, Grewal DS, Shi W, Feuer WJ, Greenfield DS. Axonal birefringence changes following surgical reduction in IOP. Presented May 6 at the 2009 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL.

101. Sinai MJ, Garway-Heath DF, Greenfield DS, Fingeret M, Varma R, Liebmann J, Schuman JS, Girkin C, Optovue Normative Database Study Group. The role of ethnicity on the retinal nerve fiber layer and optic disc area measured with Fourier Domain Optical Coherence Tomography. Presented May 5 at the 2009 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL.

102. Radcliffe NM, Sehi M, Wallace IB, Greenfield DS, Krupin T, Ritch R. Comparison of stereo disc photos and alternation flicker using a novel matching technology for deteting glaucomatous changes in the optic disc; presented at the 2009 World Glaucoma Congress, Boston, MA.

39

103. Grewal D, Goodkin ML, and Greenfield DS. Three-dimensional high-speed optical coherence tomography for diagnosis of hypotony maculopathy following glaucoma surgery; presented at the 2009 World Glaucoma Congress, Boston, MA.

104. Greenfield DS. Diagnosis and therapy of bleb-related endophthalmitis; presented at the 5th International Conference on Ocular Infections, February 19th 2010, Palm Beach, FL.

105. Grewal D, Sehi M, Greenfield DS. Detection of Progressive Retinal Nerve Fiber Layer Thickness Loss Using Scanning Laser Polarimetry with Enhanced Corneal Compensation Using Various Criteria for Functional Progression; presented March 6th at the 2010 annual meeting of the American Glaucoma Society, Naples, FL.

106. Sehi M, Grewal D, Goodkin M, Greenfield DS. Reversal of Retinal Ganglion Cell Dysfunction Following Surgical Reduction of Intraocular Pressure; presented March 5th at the 2010 annual meeting of the American Glaucoma Society, Naples, FL.

107. Kishor K, Grewal D, Sehi M, Greenfield DS, and Advanced Imaging in Glaucoma Study Group. Longitudinal detection of progressive optic disc change in glaucoma suspects and glaucomatous eyes; presented at the 2010 annual meeting of the Association for Research in Vision and Ophthalmology, Fort Lauderdale, FL.

108. Paauw J, Grewal D, Sehi M, Greenfield DS, and Advanced Imaging in Glaucoma Study Group. Detection of progressive retinal nerve fiber layer thickness loss with optical coherence tomography using various criteria for functional progression; presented at the 2010 annual meeting of the Association for Research in Vision and Ophthalmology, Fort Lauderdale, FL.

109. Grewal D, Sehi M, Greenfield DS. The impact of retardance pattern stability on retinal nerve fiber layer thickness measurements over time using scanning laser polarimetry with variable and enhanced corneal compensation; presented at the 2010 annual meeting of the Association for Research in Vision and Ophthalmology, Fort Lauderdale, FL.

110. Sehi M, Grewal D, Greenfield DS. The impact of intraocular pressure reduction on retinal ganglion cell function using pattern electroretinogram in eyes receiving latanoprost 0.005% versus placebo; presented at the 2010 annual meeting of the Association for Research in Vision and Ophthalmology, Fort Lauderdale, FL.

111. Sehi M, Grewal D, Goodkin ML, Greenfield DS. Reversal of retinal ganglion cell dysfunction following glaucoma surgery; presented April 30th at the 2010 annual Vision Research Conference (VRES), Fort Lauderdale, FL.

112. Greenfield DS. Why should we detect and treat pre-perimetric glaucoma? Presented October 16th at the 2010 annual meeting of the American Academy of Ophthalmology, Glaucoma Subspecialty Day symposium, Chicago, IL.

113. De Moraes CG, Sehi M, Chung YS, Greenfield DS, Ritch R, Liebmann JM. Prediction of risk and rates of visual field progression in patients with established, treated glaucoma; presented March 4th at the 2011 annual meeting of the American Glaucoma society, Dana Point, CA.

114. Sehi M, Bhardwaj N, Reyes MC, Chung YS, Greenfield DS. Baseline optic nerve topography and retinal nerve fiber layer thickness predicts progression in glaucoma suspect and glaucomatous eyes; presented March 5th at the 2011 annual meeting of the American Glaucoma society, Dana Point, CA.

115. Krupin T, Liebmann JM, Greenfield DS, Ritch R, Gardiner S. A randomized trial of brimonidine versus timolol in preserving visual function: Results from the Low-Pressure Glaucoma Treatment Study; presented March 4th at the 2011 annual meeting of the American Glaucoma society, Dana Point, CA.

116. Lee RK, Loo DA, Hodgson LG, Wong TY, Greenfield DS, Crowston JG. Optic nerve head vessel caliber changes in glaucoma; presented March 5th at the 2011 annual meeting of the American Glaucoma society, Dana Point, CA.

117. Huang D, Zhang XTO, Konduru R, Hwang JC, Sadda SR, Francis BA, Varma R, Sehi M, Greenfield DS. Correlation between retinal blood flow, retinal anatomy, and visual field in

40

glaucoma; presented April 30, 2011 at the 2011 annual meeting of the Association for Research in Vision and Ophthalmology/ISIE meeting, Ft. Lauderdale, FL.

118. Sehi M, Reyes MC, Konduru R, Tan O, Huang D, Greenfield DS. Retinal blood flow in glaucomatous eyes with single-hemifield damage; presented April 30, 2011 at the 2011 annual meeting of the Association for Research in Vision and Ophthalmology/ISIE meeting, Ft. Lauderdale, FL.

119. Erickson J, Reyes M, Shi W, Bhardwaj N, Sehi M, and Greenfield DS. The effect of cataract grade and location on quality of ocular imaging scans; presented May 1st at the 2011 annual meeting of the Association for Research in Vision and Ophthalmology, Fort Lauderdale, FL.

120. Niles PI, Sehi M, Bhardwaj N, Greenfield DS, and Advanced Imaging in Glaucoma Study Group. Detection of progressive macular thickness loss using optical coherence tomography in glaucoma suspect and glaucomatous eyes; presented May 2nd at the 2011 annual meeting of the Association for Research in Vision and Ophthalmology, Fort Lauderdale, FL.

121. Bhardwaj N, Sehi M, Shi W, Greenfield DS, and Advanced Imaging in Glaucoma Study Group. Macular ganglion cell thickness measurements using Fourier-Domain OCT for prediction of glaucomatous progression; presented May 4th at the 2011 annual meeting of the Association for Research in Vision and Ophthalmology, Fort Lauderdale, FL.

122. Sehi M, Bhardwaj N, Reyes MC, Chung YS, and Greenfield DS. Baseline structural measures predict functional progression in glaucoma; presented May 4th at the 2011 annual meeting of the Association for Research in Vision and Ophthalmology, Fort Lauderdale, FL.

123. Huang D, Zhang TO, Konduru R, Hwang JC, Sadda SR, Francis BA, Varma R, Sehi M, and Greenfield DS. Correlation between retinal blood flow, retinal anatomy, and visual field in glaucoma; presented April 30, 2011 at the 2011 annual meeting of the Association for Research in Vision and Ophthalmology/ISIE meeting, Ft. Lauderdale, FL.

124. Sehi M, Bhardwaj N, Reyes MC, Chung YS, and Greenfield DS. Baseline structural measures predict functional progression in glaucoma; presented June 29th at the 2011 meeting of the World Glaucoma Association, Paris, France.

125. Sehi M, Reyes MC, Konduru R, Tan O, Huang D, Greenfield DS. Retinal blood flow measurements doppler fourier-domain optical coherence tomography in glaucomatous eyes with single-hemifield damage; presented June 30th at the 2011 meeting of the World Glaucoma Association, Paris, France.

126. Lee RK, Loo DA, Hodgson LG, Wong TY, Greenfield DS, Crowston JG. Optic nerve head vessel caliber changes in glaucoma; presented October 27th at the 2011 annual meeting of the Palm Beach County Medical Society, Palm Beach, FL.

127. Huang D, Hwang JC, Konduru R, Zhang X, Tan O, Francis BA, Varma R, Sehi M, Greenfield DS, Sadda SR. Relationship among visual field, blood flow, and neural structure measurements in glaucoma; presented March 2nd at the 2012 annual meeting of the American Glaucoma Society, New York, New York.

128. De Moraes CG, Liebmann JM, Greenfield DS, Gardiner SK, Ritch R, Krupin T. Risk factors for visual field progression in the Low-Pressure Glaucoma Treatment Study; presented March 2nd at the 2012 annual meeting of the American Glaucoma Society, New York, New York.

129. Sehi M, Chung YS, Greenfield DS, Zhang X, Wollstein G, Schuman JS, Varma R, Huang D, and the Advanced Imaging in Glaucoma Study Group. Retinal nerve fiber layer loss is associated with visual field loss over time in glaucoma suspect and glaucomtaous eyes; presented March 2nd at the 2012 annual meeting of the American Glaucoma Society, New York, New York.

130. Teng CC, De Moraes CG, Liebmann JM, Greenfield DS, Gardiner SK, Ritch R, and Krupin T for the LoGTS Investigators. Risk factors for optic disc hemorrhage in the Low-

41

pressure Glaucoma Treatment Study; presented at the 2012 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL.

131. Shah M, Zhang X, Varma R, Greenfield DS, Schuman JS, Huang D, AIGS Group. Baseline nerve fiber layer and ganglion cell complex thickness by optical coherence tomography as risk factors for the development of glaucomatous visual field defects; presented at the 2012 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL.

132. Bhardwaj N, Niles PI, Greenfield DS, Hymowitz MB, Sehi M, Feuer WJ, Budenz DL. The impact of surgical intraocular pressure reduction on vsual function using various criteria to define visual field progression; presented at the 2012 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL.

133. Martino AZ, Iverson SM, Feuer WJ, Greenfield DS. Surgical outcomes of superior versus inferior glaucoma drainage device implantation; presented at the 2012 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL.

134. Huang D, Zhang X, Varma R, Greenfield DS, Schuman JS, and the Advanced Imaging for Glaucoma Study Group. Nerve fiber layer and ganglion cell complex measurements by optical coherence tomography as risk factors for visual field progression in glaucoma; presented at the 2012 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL.

135. Iverson SM, Sehi M, Harvey B, Greenfield DS, and the Advanced Imaging for Glaucoma Study (AIGS) Group. Evaluation of optic disc progression in glaucoma using spectral domain optical coherence tomography; presented at the 2012 annual meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL.

136. Greenfield DS. Normal-Tension Glaucoma: How I treat patients progressing at low intraocular pressure; presented November 10 at 2012 Annual Meeting of the American Academy of Ophthalmology Glaucoma Subspecialty Day Meeting, Chicago, IL

137. Chung YS, Sehi M, Greenfield DS. Baseline risk factors predicting glaucomatous visual field progression in glaucoma suspects and glaucoma patients; presented December 14th 2012 at the 8th International Symposium of Ophthalmology, Hong Kong.

138. Goharian I, Greenfield DS, Sehi M. Cluster-based trend analysis of visual field progression in low-tension and high-tension open-angle glaucoma; presented at the 2013 annual meeting of the Association for Research in Vision and Ophthalmology, Seattle, WA.

139. Iverson SM, Sehi M, Feuer WJ, Greenfield DS, and the Advanced Imaging for Glaucoma Study (AIGS) Group. Frequency of abnormal retinal nerve fiber layer and ganglion cell layer SDOCT scans in healthy eyes and glaucoma suspects; presented at the 2013 annual meeting of the Association for Research in Vision and Ophthalmology, Seattle, WA.

140. Papchristou GC, Greenfield DS, O’Brien TP, Schiffman J, Shi W, Iverson S. Comparison of graft survival following penetrating keratoplasty and descemet’s stripping endothelial keratoplasty in medically and surgically treated glaucoma patients; presented at the 2013 annual meeting of the Association for Research in Vision and Ophthalmology, Seattle, WA.

141. Schultz SK, Iverson SM, Shi W, Schiffman JC, Greenfield DS. Long-term outcomes of filtration surgery for normal-tension glaucoma with visual field progression at low intraocular pressure; presented at the 2013 annual meeting of the Association for Research in Vision and Ophthalmology, Seattle, WA.

142. Sehi M, Goharian I, Konduru R, Tan O, Srinivas S, Sadda S, Huang D, Greenfield DS. Reduced retinal blood flow is associated with thinner retinal nerve fiber layer in glaucomatous eyes with single hemifield damage; presented at the 2013 annual meeting of the Association for Research in Vision and Ophthalmology, Seattle, WA.

42

143. Teng CC, DeMoraes CG, Liebmann JM, Greenfield DS, Ritch R, Krupin T, for the LoGTS Investigators. Central corneal thickness and IOP response to topical ocular hypotensive medication in the Low-pressure Glaucoma Treatment Study; presented at the 2013 annual meeting of the Association for Research in Vision and Ophthalmology, Seattle, WA.

144. Tan O, Zhang X, Loewen N, Schuman J, Greenfield DS, Varma R, Huang D, and the AIGS Group. The effect of image quality on the reliability of nerve fiber layer measurements with fourier-domain OCT; presented at the 2013 annual meeting of the Association for Research in Vision and Ophthalmology, Seattle, WA.

145. Schultz SK, Greenfield DS, Iverson SM, Shi W. Achieving single digit IOP control with filtration surgery in eyes with progressive normal-tension glaucoma; presented at the 2014 annual meeting of the American Glaucoma Society, Washington DC.

146. Maharaj A, Greenfield DS, Iverson SM, Goharian I, Sehi M, Zhang X, Huang D, Schuman JS, Varma R, Francis BA. Progressive retinal nerve fiber layer atrophy is associated with reduced central corneal thickness in glaucoma suspect and glaucomatous eyes; presented at the 2014 annual meeting of the American Glaucoma Society, Washington DC.

147. Iverson SM, Schultz SK, Shi W, Feuer WJ, Greenfield DS. Effectiveness of achieving single digit IOP targets with filtration surgery on decreasing global and localized visual field progression in eyes with progressive normal-tension glaucoma; presented at the 2014 annual meeting of the Association for Research in Vision and Ophthalmology, Orlando, FL.

148. Chan J, De Moraes CG, Weinreb RN, Greenfield DS, Krupin T, Gardiner SK, Liebmann JM, Ritch R, for the Low-Pressure Glaucoma Treatment Study Group. Baseline visual field damage as a predictor of faster rates of visual field progression in the Low-pressure Glaucoma Treatment Study; presented at the 2014 annual meeting of the Association for Research in Vision and Ophthalmology, Orlando, FL.

149. Goharian I, Iverson SM, Ruiz RC, Kishor K, Greenfield DS, Sehi M. Retinal oxygen saturation in treated glaucomatous eyes; presented at the 2014 annual meeting of the Association for Research in Vision and Ophthalmology, Orlando, FL.

150. Maharaj AS, Sehi M, Greenfield DS, , Iverson SM, Goharian I, Zhang X, Francis BA, Schuman JS, Varma R, Huang D. Progressive retinal nerve fiber layer atrophy is associated with thin central corneal thickness in glaucoma suspect and glaucomatous eyes; presented at the 2014 annual meeting of the Association for Research in Vision and Ophthalmology, Orlando, FL.

151. Sehi M, Greenfield DS, Kishor K, Ruiz RC, Srinivas S, Iverson SM, Goharian I. Relationship between retinal blood flow, ganglion cell function, and retinal oxygenation in glaucomatous and normal eyes; presented at the 2014 annual meeting of the Association for Research in Vision and Ophthalmology, Orlando, FL.

152. Wright T, Goharian I, Gardiner SK, Greenfield DS, Sehi M. Enhancement of visual field sensitivity in glaucomatous eyes following surgical intraocular pressure reduction; presented at the 2014 annual meeting of the Association for Research in Vision and Ophthalmology, Orlando, FL.

153. De Moraes CG, Liebmann JM, Greenfield DS, Ritch R, and Krupin T. Reliability indices, sensitivity loss, and rates of visual field change in glaucoma; presented at the 2014 annual meeting of the Association for Research in Vision and Ophthalmology, Orlando, FL.

154. Greenfield DS. Clinical evidence of neuroprotection: Results from the Low-Pressure Glaucoma Treatment Study (LoGTS), World Ophthalmology Congress, Tokyo, Japan, April 4, 2014.

155. Huang D, Zhang X, Loewen NA, Tan O, Francis BA, Varma R, Greenfield DS, Schuman JS. Predicting glaucomatous visual field damage with Fourier-domain optical coherence tomography in the Advanced Imaging for Glaucoma Study; presented at the 2014 annual meeting of American Academy of Ophthalmology, Chicago, IL.

43

156. Sehi M, Zhang X, Huang D, Loewen NA, Tan O, Francis BA, Varma R, Greenfield DS, Schuman JS. Baseline structural risk factors for functional progression in the Advanced Imaging for Glaucoma Study; presented at the 2014 annual meeting of American Academy of Ophthalmology, Chicago, IL.

157. Zhang X, Francis B, Tan O, Varma R, Greenfield DS, Schuman JS, Loewen NA, Sehi M, Huang D. Longitudinal and cross-secional analyses of age and intraocular pressure effects on retinal nerve fiber layer and ganglion cell complex thickness; presented at the 2015 annual meeting of the American Glaucoma Society, Coronado, CA.

158. Goharian I, Shaw J, Gardiner SK, Wright TM, Greenfield DS. Long-term evaluation of visual field enhancement in glaucomatous eyes following surgical intraocular pressure reduction; presented at the 2015 annual meeting of the Association for Research in Vision and Ophthalmology, Denver, CO.

159. Wright TM, Goharian I, Feuer WJ, Shi W, Greenfield DS. Three-year outcomes of glaucoma drainage device surgery in eyes with and without prior conjunctival incisional surgery; presented at the 2015 annual meeting of the Association for Research in Vision and Ophthalmology, Denver, CO.

160. Srinivas S, Tan O, Nittala MG, Varma R, Francis B, Greenfield DS, Parrish R, Schuman JS, Sadda SR, Huang D, and the Advanced Imaging for Glaucoma Study Group. Quantitative analysis of retinal blood flow in normal and glaucomt eyes by Doppler Fourier-Domain Optical Coherence Tomography; presented at the 2015 annual meeting of the Association for Research in Vision and Ophthalmology, Denver, CO.

44

Invited Lectures: 1. Automated Perimetry: Intrepretation of reliability and global indices, The Greater New York OKAP Review Course, Beth Israel Medical Center, New York, NY, 2-96. 2. Simultaneous stereoscopic optic disc photography, The Boston Glaucoma Course: Imaging in Glaucoma, New England Eye Center, Boston, MA, 3-96. 3. Bilateral lateral geniculitis associated with severe diarrhea, The Manhattan Ophthalmological Society, New York, NY, 3-96. 4. Endophthalmitis following glaucoma filtration surgery with mitomycin C, St. Vincents Medical Center, Department of Ophthalmology Grand Rounds, New York, NY, 4-96 5. The medical treatment of glaucoma: mechanisms of action and toxicity, Prevent Blindness New York, glaucoma support and education group, New York, NY, 6-96. 6. Glaucomatous vs. non-glaucomatous cupping of the optic nerve head: Tips for clinical differentiation, Lincoln Hospital, New York Medical College, NY, 8-96. 7. Glaucomatous vs. non-glaucomatous cupping of the optic nerve head: Tips for clinical differentiation, Downstate Medical Center, Department of Ophthalmology Grand Rounds, NY, 9-96. 8. Glaucomatous vs. non-glaucomatous cupping of the optic nerve head, St. Vincent’s Hospital, Department of Ophthalmology Grand Rounds, NY, 9-96.

9. Normal-tension glaucoma, Nassau County Medical Center, Department of Ophthalmology Grand Rounds, NY, 10-96. 10. Normal-tension glaucoma, St. Luke’s-Roosevelt Medical Center, Department of Ophthalmology Grand Rounds, NY, 10-96. 11. Normal-tension glaucoma, NYU Medical Center, Department of Ophthalmology Grand Rounds, NY, 10-96. 12. Ocular imaging in glaucoma, Connecticut Visual Health Seminar, CT, 12-96. 13. Telemedicine at the New York Eye and Ear Infirmary, Marist College, NY, 1-97. 14. Glaucoma: New strategies in detection & treatment symposium, New York, NY, 1-97. 15. Scanning laser polarimetry in glaucomatous and non-glaucomatous optic neuropathy, Brewster, MA, 7-97. 16. New strategies in glaucoma detection and medical management, Steamboat Springs, CO, 1-98. 17. Ocular imaging in glaucoma, Steamboat Springs CO, 1-98. 18. Medical management of glaucoma: new developments, Israeli Glaucoma Society, Tel Aviv,

Israel, 2-98. 19. Neuroprotection and non-pressure-dependent glaucoma, Curso de Pos-Graduacao

Oftalmologia en Glaucoma, Porto, Portugal, 3-98.

45

INVITED LECTURES (cont.): 20. New strategies in open-angle glaucoma management, American Optometric Association,

Orlando, FL, 6-98 21. Normal-tension glaucoma protocols, American Optometric Association, Orlando, FL, 6-98.

22. Ocular imaging in glaucoma, XX Inter-American Course in Clinical Ophthalmology, Miami, FL, 11-98.

23. Bleb-related endophthalmitis: an update. XX Inter-American Course in Clinical Ophthalmology, Miami, FL, 11-98.

24. New Strategies in glaucoma management, Copper Mountain, CO, 1-99 25. Scanning laser polarimetry and optical coherence tomography in glaucoma. Salzburg

Ophthalmologic Symposium, Salzburg, Austria, 3-99. 26. Advances in medical therapy for glaucoma, Atlanta, GA, 4-99 27. Scanning Laser Polarimetry in glaucoma management, 35th Annual Bascom Palmer Eye

Institute Resident’s Day, Miami, FL, 6-99. 28. Neuroimaging, blood flow studies, laboratory examination: Are they useful in LTG?

Glaucoma 1999 Subspecialty Day Program, Orlando, FL, 10-99. 29. Glaucoma in the next millenium: New concepts, new diagnostic technologies, new

therapeutic strategies. Tennessee Ophthalmology Society, Knoxville, TN, 10-99. 30. Topographical imaging and nerve fiber layer assessment in glaucoma. International

Ophthalmology Symposium of Ophthalmology – 2000, Tel Aviv, Israel, 3-2000. 31. Medical therapy for glaucoma in the next millenium, Columbia, SC, 4-2000. 32. Management of the flat anterior chamber. East Coast Glaucoma Symposium, New York, NY,

6-2000 33. Bleb infections. East Coast Glaucoma Symposium, New York, NY, 6-2000. 34. Ocular blood flow in glaucoma: Clinical relevance, Jackson Hole, WY, 9-2000. 35. Malignant Glaucoma Syndromes. Glaucoma 2000 Subspecialty Day Program, Dallas, TX, 10-

00. 36. Imaging of the optic nerve and retinal nerve fiber layer: An update, XXII Inter-American

Course in Clinical Ophthalmology, Miami, FL, 10-00. 37. New horizons in glaucoma therapy, Jackson, Mississippi, 12-00. 38. Quantitative assessment of the retinal nerve fiber layer, Indianapolis, IN, 12-00. 39. Quantitative assessment of the retinal nerve fiber layer: Where we are and where we are

going. Brooklyn Ophthalmological Society, 01-01. 40. Cupped discs and low pressures: Clinical differentiation of glaucomatous and non-

glaucomatous optic disc cupping. Brooklyn Ophthalmological Society, 01-01. 41. Non-pressure dependent glaucoma: A vascular perspective. Birmingham, Alabama, 01-01. 42. Ocular blood flow in glaucoma: Clinical relevance. Tampa, Florida, 2-01. 43. New Horizons in glaucoma therapy. Port Everglades, FL, 3-01. 44. Dysfunctional glaucoma filtration blebs. Wilmer Eye Institute, Johns Hopkins University

School of Medicine, Current Concepts in Ophthalmology, Vail, Colorodo, 3-01. 45. Target IOP: Strategies for success. Wilmer Eye Institute, Johns Hopkins University School of

Medicine, Current Concepts in Ophthalmology, Vail, Colorodo, 3-01. 46. Glaucoma drainage implants: Indications and techniques. Wilmer Eye Institute, Johns

Hopkins University School of Medicine, Current Concepts in Ophthalmology, Vail, Colorodo, 3-01.

47. Dysfunctional glaucoma filtration blebs. Orlando, FL, 3-01. 48. Scanning laser polarimetry image interpretation, Asheville, NC, 4-01. 49. New horizons in glaucoma therapy. Charlotte, NC, 5-01.

46

INVITED LECTURES (cont.): 50. Ocular imaging in glaucoma: Are we there yet? Central Florida Society of Ophthalmology,

Orlando, FL, 5-01. 51. Target Intraocular Pressure: Strategies for success. Tampa, FL, 5-01 52. Target Intraocular Pressure: Strategies for success. San Mateo, CA, 6-01. 53. Pressure Dependent and Independent Factors in Glaucoma. XXII PanAmerican Congress of

Ophthalmology, Buenos Aires, Argentina, 7-01. 54. The role of blood flow in glaucoma therapy, Jules Stein Eye Institute, UCLA School of

Medicine, 8-01 55. Ocular imaging in glaucoma, Ocular Surgery News Symposium, New York City, NY, 9-01. 56. Taking measure of glaucoma: Are we there yet? Jacksonville, FL, 9-01. 57. Taking measure of glaucoma: Are we there yet? New Jersey Academy of Ophthalmology,

Eatontown, NJ, 10-01. 58. Dysfunctional glaucoma filtration blebs. New Jersey Academy of Ophthalmology,

Eatontown, NJ, 10-01. 59. Pressure dependent and independent factors in glaucoma. Iowa Optometric Association,

Cedar Rapids, Iowa, 10-01. 60. Dysfunctional glaucoma filtration blebs. Iowa Optometric Association, Cedar Rapids, Iowa,

10-01. 61. Automated Detection of Glaucomatous Structural Change – Are we there yet? Glaucoma

2001 Subspecialty Day Program, New Orleans, LA, 11-01. 62. Point – Counterpoint: Retinal nerve fiber layer analysis is best for glaucoma detection. 2002

Royal Hawaii Eye Meeting, Kona, HI, 1-02. 63. GDx Image Interpretation, 2002 Royal Hawaii Eye Meeting, Kona, HI, 1-02. 64. Optical Coherence Tomography in glaucomatous optic neuropathy, 2002 Royal Hawaii Eye

Meeting, Kona, HI, 1-02. 65. Retinal nerve fiber layer analysis in glaucoma. 2002 Royal Hawaii Eye Meeting, Kona, HI, 1-

02. 66. Ocular imaging in glaucoma: Are we there yet? Palm Beach, FL, 2-02. 67. Taking measure of glaucoma. Texas Optometric Association, Austin, TX, 2-02. 68. Optical coherence tomography in glaucoma. Texas Optometric Association, Austin, TX, 2-02 69. Update: Ocular imaging in glaucoma. 2002 Ocular Drug and Surgical Therapy Update, Dana

Point, CA, 2-02 70. Glaucoma drainage implants: Indications and techniques. Wilmer Eye Institute, Johns

Hopkins University School of Medicine, Current Concepts in Ophthalmology, Vail, Colorodo, 3-02.

71. Ocular imaging in glaucoma: Are we there yet? Wilmer Eye Institute, Johns Hopkins University School of Medicine, Current Concepts in Ophthalmology, Vail, Colorodo, 3-02.

72. Glaucoma Drainage Implants: Evolution and Revolution. Italian Ophthalmological Society, Naples, Italy, 4-02.

73. Target IOP: Evidence based stratregies, Cancun, Mexico, 5-02. 74. Maximal medical therapy: One bottle or two? Cancun, Mexico, 5-02. 75. Clinical recognition of the glaucomatous disc and its progression: Glaucoma 2002:

Contemporary issues in glaucoma diagnosis and therapy, New York City, NY 6-02. 76. Bleb infections. Glaucoma 2002: Contemporary issues in glaucoma diagnosis and therapy,

New York City, NY 6-02.

47

INVITED LECTURES (cont.): 77. Differential diagnosis of normal-tension glaucoma. Glaucoma 2002: Contemporary issues in glaucoma diagnosis and therapy, New York City, NY 6-02. 77. Ocular imaging in glaucoma: an update, Fort Meyers, FL, 6-02. 78. Targeting the patient in glaucoma management, Boston, MA, 6-02 79. Targeting the patient in glaucoma management, New York City, NY 6-02. 80. Targeting the patient in glaucoma therapy, Palm Beach Ophthalmology Society, Boca Raton,

FL 6-02 81. New concepts in glaucoma: results of recent clinical trials, Jacksonville, FL, 8-02 82. New concepts in glaucoma: results of recent clinical trials, Miami, FL, 8-02 83. New concepts in glaucoma: results of recent clinical trials, Ashville, NC, 9-02 84. New concepts in glaucoma: results of recent clinical trials, Detroit, MI, 9-02 85. New concepts in glaucoma: results of recent clinical trials, Pittsburgh, PA, 9-02 86. Taking measure of glaucoma: Scanning laser polarimetry, Glaucoma 2002 Subspecialty Day

Program, Orlando, FL, 10-02. 87. Pressure dependent and independent variables in glaucoma. 2002 Annual meeting of the

Curso, Miami, FL, 10-02. 88. Taking measure of glaucoma: advances in ocular imaging for glaucoma. 2002 Annual

meeting of the Curso, Miami, FL, 10-02 89. What have we learned from recent clinical trials in glaucoma? Columbus, OH, 11-02. 90. The ocular hypertension study: translation into clinical practice. Miami, FL, 11-02 91. Pressure dependent and independent factors in glaucoma. Hamburg, Germany, 11-02 92. Pressure dependent and independent factors in glaucoma. Copenhagen, Denmark, 11-02 93. The normal-tension glaucoma study: What have we learned? The New York Society of

Clinical Ophthalmology, 12-02. 94. Clinical assessment of the retinal nerve fiber layer. 2003 Royal Hawaii Eye Meeting, Maui,

HI, 1-03. 95. Treatment of bleb infections. 2003 Royal Hawaii Eye Meeting, Maui, HI, 1-03. 96. Scanning laser polarimetry with variable corneal compensation. 2003 Royal Hawaii Eye

Meeting, Maui, HI, 1-03. 97. Clinical assessment of the retinal nerve fiber. 2003 Ocular Drug and Surgical Therapy

Update, Dana Point, CA, 2-03. 98. Retinal nerve fiber assessment. Palm Beach Optometric Association, Palm Beach, FL, 3-03. 99. Evidence Based Decisions in Glaucoma, Acapulco, Mexico, 3-03. 100. Assessment of Structure and Function in Glaucoma. Sarasota, FL, 4-03. 101. A paradigm shift in glaucoma assessment, Phoenix, AZ, 4-03 102. Individualized risk assessment in OHT, Phoenix, AZ, 4-03. 103. Clinical implications of the Ocular Hypertension Treatment Trial, Canadian

Ophthalmological Society, Montreal, Canada, 5-03. 104. Clinical recognition of glaucomatous disc damage and its progression, Canadian

Ophthalmological Society, Montreal, Canada, 5-03. 105. Clinical applications of optic nerve imaging devices, Canadian Ophthalmological Society,

Montreal, CA, 5-03. 106. Recognition of the glaucomatous optic disc and it’s progression, Glaucoma 2003, Chicago,

IL, 6-03 107. The normal-tension glaucoma study: Can I save the sight of my patient? Glaucoma 2003,

Chicago, IL, 6-03. 108. Evidence-based factors in glaucoma management, Montreal, Canada, 6-03.

48

INVITED LECTURES (cont.):

109. Imaging in glaucoma: Evolution and revolution, Coral Gables, FL, 9-03 110. Recognition of the glaucomatous optic disc and it’s progression, Fort Worth, TX, 9-03 111. Imaging in glaucoma: Evolution and revolution, Fort Lauderdale, FL, 10-03 112. Imaging in glaucoma: Evolution and revolution, Sarasota, FL, 10-03. 113. Translating OHTS into clinical practice, Vancouver, Canada, 10-03. 114. Clinical recognition of glaucomatous optic nerve damage, Vancouver, 10-03 115. Imaging in glaucoma: Evolution and revolution, Madison, WI, 2-04 116. Selective Laser Trabeculoplasty: Fact and Fiction, Palm Beach Ophthalmologic Society,

Palm Beach, FL, 2-04 117. New Developments in Ocular Imaging, Las Vegas, NV, 2-04 118. Taking Measure of Glaucoma. Wilmer Eye Institute, Johns Hopkins University School of

Medicine, Current Concepts in Ophthalmology, Durado Beach, Puerto Rico, 2-04. 119. Target IOP: An evidence-based approach. Wilmer Eye Institute, Johns Hopkins University

School of Medicine, Current Concepts in Ophthalmology, Durado Beach, Puerto Rico, 2-04. 120. Clinical recognition of the glaucomatous disc and it’s progression. Ocular imaging in

glaucoma: Are we there yet? Wilmer Eye Institute, Johns Hopkins University School of Medicine, Current Concepts in Ophthalmology, Durado Beach, Puerto Rico, 2-04.

121. Taking Measure of Glaucoma. Wilmer Eye Institute, Johns Hopkins University School of Medicine, Current Concepts in Ophthalmology, Vail, CO, 3-04.

122. Target IOP: An evidence-based approach. Wilmer Eye Institute, Johns Hopkins University School of Medicine, Current Concepts in Ophthalmology, Vail, Colorodo, 3-04.

123. Clinical recognition of the glaucomatous disc and it’s progression. Ocular imaging in glaucoma: Are we there yet? Wilmer Eye Institute, Johns Hopkins University School of Medicine, Current Concepts in Ophthalmology, Vail, Colorodo, 3-04.

124. Tubes and Trabs: How to choose. New Concepts and Treatment Strategies in Glaucoma, New Orleans, LA, 4-04.

125. Imaging in glaucoma: an update. New Concepts and Treatment Srategies in Glaucoma, New Orleans, LA, 4-04.

126. Target IOP: Pearls & Pitfalls, Chicago, IL, 5-04 127. Advanced concepts in identifying glaucoma progression, Orlando, FL, 6-04. 128. Advanced concepts in identifying glaucoma progression, Palm Beach Gardens, FL, 6-04. 129. Imaging in glaucoma: Does it add to clinical care? Lansing, MI, 9-04 130. Advanced concepts in identifying glaucoma progression, Boca Raton, FL, 9-04 131. Advanced concepts in identifying glaucoma progression, Melbourne, FL, 10-04. 132. Imaging in glaucoma: Does it add to clinical care? Minneapolis, MN, 10-04 133. Imaging technologies in glaucoma. 2004 American Academy of Ophthalmology ARVO

symposium, New Orleans, LA 10-04. 134. Structure and Function in Glaucoma, Dallas, TX, 11-04 135. Glaucoma 2005: What I am doing different, Boca Raton, FL, 12-04 136. Retinal nerve fiber layer analysis, World Glaucoma Forum, Rome, 1-05. 137. Ocular Imaging in Glaucoma: Does it add to clinical care? Columbia, SC 1-05 138. Ocular Imaging in Glaucoma: Does it add to clinical care? Chicago Ophthalmology

Society, 2-05. 139. Ocular Imaging in Glaucoma. Kansas City, MO, 2-05 140. Clinical recognition of the glaucomatous disc and it’s progression. Wilmer Eye Institute, Johns Hopkins University School of Medicine, Current Concepts in Ophthalmology, Vail, Colorodo, 3-05

49

INVITED LECTURES (cont.): 141. Target IOP: An evidence-based approach. Wilmer Eye Institute, Johns Hopkins University

School of Medicine, Current Concepts in Ophthalmology, Vail, Colorodo, 3-05. 142. Imaging in Glaucoma. Wilmer Eye Institute, Johns Hopkins University School of

Medicine, Current Concepts in Ophthalmology, Vail, Colorodo, 3-05. 143. Non-glaucomatous optic nerve damage. Wilmer Eye Institute, Johns Hopkins University

School of Medicine, Current Concepts in Ophthalmology, Vail, Colorodo, 3-05. 144. Optical coherence tomography in Glaucoma. Wilmer Eye Institute, Johns Hopkins

University School of Medicine, Current Concepts in Ophthalmology, Vail, Colorodo, 3-05. 145. How do I use imaging devices to diagnose glaucoma and monitor progression? American

Society of Cataract and Refractive Surgery (ASCRS) 2005 Glaucoma Day, Washington D.C., 4-05

146. Should everyone receive an antifibrosis agent during trabeculectomy? American Society of Cataract and Refractive Surgery (ASCRS) 2005 Glaucoma Day, Washington D.C., 4-05

147. Should we retire ocular beta-blockers for initial glaucoma monotherapy? American Society of Cataract and Refractive Surgery (ASCRS) 2005 Glaucoma Day, Washington D.C., 4-05

148. Should we be performing the new laser procedures in glaucoma? Miami Beach, FL, 5-05. 149. Tube shunts and trabeculectomy: How to choose. University of Pittsburgh School of

Medicine, Pittsburgh, PA, 5-05. 150. Controversies in glaucoma surgery. University of Montreal, Montreal, Canada, 6-05 151. Clinical recognition of glaucomatous optic neuropathy. Montreal, Canada, 6-05 152. Imaging in glaucoma: How does it add to clinical care? Sherbrooke, Canada, 6-05 153. Imaging in glaucoma: an update. New York, NY, 6-05 154. Imaging in glaucoma: an update, Roslyn, NY, 6-05. 155. Non-penetrating glaucoma surgery, Baltimore, MD, 6-05 156. Glaucoma drainage device surgery, Baltimore, MD, 6-05. 157. Initial glaucoma therapy. Fort Lauderdale, FL, 9-05. 158. Initial glaucoma therapy, Oklahoma City, OK, 9-05 159. New advances in ocular imaging, Boston, MA, 9-05 160. New advances in ocular imaging, Bedford, NH, 9-05. 161. Initial medical therapy of glaucoma, Orlando, FL, 11-05 162. Risk assessment in ocular hypertension, Boston, MA, 12-05 163. Risk assessment in ocular hypertension, Agawam, MA 12-05 164. Targeting high risk individuals with ocular hypertension, Ft. Meyers, FL, 12-05 165. Targeting high risk individuals with ocular hypertension, Minneapolis, MN, 12-05 166. Targeting high risk individuals with ocular hypertension, Mobile, AL, 1-06 167. Targeting high risk individuals with ocular hypertension, Pensacola, FL, 1-06 168. Controversies in normal-tension glaucoma. Wilmer Eye Institute, Johns Hopkins University

School of Medicine, Current Concepts in Ophthalmology, Vail, Colorodo, 3-06. 169. Imaging in glaucoma: an update. Wilmer Eye Institute, Johns Hopkins University School of

Medicine, Current Concepts in Ophthalmology, Vail, Colorodo, 3-06. 170. Glaucoma drainage devices. Wilmer Eye Institute, Johns Hopkins University School of

Medicine, Current Concepts in Ophthalmology, Vail, Colorodo, 3-06. 171. The future of structural testing in glaucoma, Beijing, China, 3-06 172. First line therapy in glaucoma management, Birmingham, AL, 6-06 173. Global risk assessment in glaucoma, Tuscalusa, AL, 6-06. 174. Controversies in normal-tension glaucoma, Palm Beach Gardens, FL, 7-06 175. Controversies in normal-tension glaucoma, Stuart, FL, 8-06 176. Controversies in normal-tension glaucoma, Melbourne, FL, 9-06. 177. Practical applications of imaging in glaucoma, Houston, TX, 10-06.

50

178. Optic nerve imaging for assessment of risk in ocular hypertension, Palm Beach Ophthalmology Society, Jupiter, FL, 12-06

179. Clinical assessment of glaucoma progression, Portland, ME, 12-07. 180. Clinical assessment of glaucoma progression, Lexington, MA, 12-07. 181. Clinical assessment of glaucoma progression, New York, NY, 12-07 182. Clinical assessment of glaucoma progression, Great Neck, NY, 2-08. 183. Optic nerve imaging for glaucoma diagnosis and monitoring, Palm Beach Ophthalmology

Society, Palm Beach Gardens, FL, 2-08. 184. Glaucoma diagnosis and monitoring: A paradigm shift, University of Illinois at Chicago,

Illinois Eye and Ear Infirmary, Chicago, FL, 5-08. 185. Role of imaging in glaucoma clinical practice, Jacksonville, FL, 6-08 186. Role of imaging in glaucoma clinical practice, Gainsville, FL, 6-08. 187. Optic nerve imaging and risk assessment for glaucoma management. Miami

Ophthalmological Society, Miami, FL, 8-08. 188. Advances in glaucoma diagnosis and monitoring. Chicago, IL, 9-08. 189. The five “R’s” of glaucomatous structural progression. Toronto, Canada, 9-08. 190. Detection of glaucomatous optic disc and retinal nerve fiber layer progression, New York,

NY, 12-08. 191. Assessment of the Optic Disc and Retinal Nerve Fiber Layer, La Jolla, CA, 1-09. 192. Detection of Glaucomatous structural and functional progression, American Osteopathic

Colleges of Ophthalmology and Otolaryngology-Head and Neck Surgery Foundation, Austin, TX 5-09.

193. Why I prefer trabeuletomy for initial glaucoma surgery. New York Glaucoma Society, NY, NY, 6-09.

194. Role of imaging for detection of glaucoma progression. Brisbane, Australia, 8-09. 195. Role of imaging for detection of glaucoma progression. Sydney, Australia, 8-09. 196. Why I prefer trabeculectomy for initial glaucoma surgery. Melbourne, Australia, 8-09. 197. Reversal of retinal ganglion cell dysfunction following surgical reduction of intraocular

pressure. Melbourne, Australia, 8-09. 198. Bleb related ocular infection, 5th International Conference on Ocular Infection, February

18-21 2010 Palm Beach, FL. 199. The future of ocular imaging in glaucoma, Sinai Hospital, Baltimore, Maryland, February

25, 2010. 200. Unlocking mysteries in the measurement of the retinal nerve fiber layer, 11th annual

Clinician-Scientist Lecture, annual meeting of the American Glaucoma Society, Naples, Florida, 3-6-2010.

201. The future of ocular imaging in glaucoma, University of Toronto, 3-25-2010. 202. Detecting structural progression in glaucoma, “Glaucoma Management: Beyond IOP

Control”, May 8, 2010, San Diego, CA. 203. The future of ocular imaging in glaucoma, San Francisco, CA, September 24, 2010. 204. Detection of glaucoma progression, New York City, NY, December 2, 2010. 205. The Low-Pressure Glaucoma Treatment Study (LoGTS), Paris, France, January 16, 2011 206. The Low-Pressure Glaucoma Treatment Study (LoGTS), Singapore, February 5, 2011. 207. Introduction to the 1st annual AGS Innovator Award, 2011annual meeting of the American

Glaucoma Society, Dana Point, CA, March 3, 2011. 208. Introduction to the 12th annual Clinician-Scientist Lecture (Joel Schuman, MD), 2011

annual meeting of the American Glaucoma Society, Dana Point, CA, March 5, 2011. 209. The Low-Pressure Glaucoma Treatment Study (LoGTS), annual meeting of the Asia

Pacific Academy of Ophthalmology, Sydney, Australia, March 21, 2011 210. The Low-Pressure Glaucoma Treatment Study (LoGTS), Mombay, India, March 23, 2011. 211. The Low-Pressure Glaucoma Treatment Study (LoGTS), Delhi, India, March 25, 2011.

51

212. Introduction to the 2nd annual AGS Innovator Award, 2012 annual meeting of the American Glaucoma Society, New York, NY, March 1, 2012.

213. Introduction to the 13th annual Clinician-Scientist Lecture (James Brandt, MD), 2012 annual meeting of the American Glaucoma Society, New York, NY, March 53, 2012

214. Factors influencing visual field progression and clinical management strategies in normal-tension glaucoma, Tokyo, Japan, April 5th, 2012

215. Factors influencing visual field progression and clinical management strategies in normal-tension glaucoma, Wills Eye Hospital, Philadelphia, PA, May 9, 2011.

216. Factors influencing visual field progression and clinical management strategies in normal-tension glaucoma, Illinois Eye and Ear Infirmary, University of Illinois at Chicago, Chicago, IL, May 16, 2012.

217. Factors influencing visual field progression and clinical management strategies in normal-tension glaucoma, University of Colorado Hospital Eye Center, Denver, CO, October 12, 2012.

218. Factors influencing visual field progression and clinical management strategies in normal-tension glaucoma, NYU Medical Center, New York, NY, December 4, 2012.

219. The future of imaging in glaucoma, New York Glaucoma Society, New York, NY, December 4, 2012

220. Introduction to the 4th annual American Glaucoma Society Surgery Lecture (Marlene Moster, MD), 2013 annual meeting of the American Glaucoma Society, San Francisco, CA, February 28, 2013.

221. Normal-Tension Glaucoma: Factors influencing visual field progression and clinical management strategies, Seoul National University Hospital, Seoul, Korea, April 15, 2013.

222. Neuroprotection and Lessons from the Low Pressure Glaucoma Treatment Study, Seoul National University Hospital, Seoul, Korea, April 15, 2013.

223. Normal-Tension Glaucoma: Factors influencing visual field progression and clinical management strategies, Seoul Asan Medical Center, Seoul, Korea, April 16, 2013.

224. The Future of Imaging in Glaucoma, St. Louis University Visiting Professorship, St. Louis, MO, April 18, 2013.

225. Normal-Tension Glaucoma: Factors influencing visual field progression and clinical management strategies, St. Louis Ophthalmology Society, St. Louis, MO, April 18, 2013.

226. Advanced Imaging Techniques in Glaucoma, Northwestern University, Chicago, IL, October 4 2013.

227. 2013 Mansour F. Armaly Lecture, University of Iowa Hospitals and Clinics, Department of Ophthalmology and Visual Sciences, “Normal-Tension Glaucoma: Factors Influencing Visual Field Progression and Clinical Management Strategies”.

228. Introduction to the 5th annual AGS Glaucoma Surgery Day Award (Paul F Palmberg, MD, PhD), 2014 annual meeting of the American Glaucoma Society, Washington DC, February 27, 2014.

229. Clinical evidence of neuroprotection: Results from the Low-Pressure Glaucoma Treatment Study (LoGTS), World Ophthalmology Congress, Tokyo, Japan, April 4, 2014.

230. Clinical evidence of neuroprotection: Results from the Low-Pressure Glaucoma Treatment Study (LoGTS), Shanghai Eye and ENT Hospital, Shanghai, China, April 8, 2014

231. Clinical evidence of neuroprotection: Results from the Low-Pressure Glaucoma Treatment Study (LoGTS), Chengdu, China, April 9, 2014

232. Introduction to the 25th annual AGS Lecture (Paul Lee, MD), 2015 annual meeting of the American Glaucoma Society, Coronado, CA, February 27, 2015.

233. Introduction to the 25th annual AGS Guest of Honor (David L. Epstein, MD), 2015 annual meeting of the American Glaucoma Society, Coronado, CA, February 27, 2015

234. Ocular perfusion pressure as a risk factor for glaucoma: Practical considerations, 6th World Glaucoma Congress, Hong Kong, June 9, 2015.

52

235. Glaucoma at low tension: When normal isn’t good enough. Dalhousie University, Department of Ophthalmology & Visual Sciences Visiting Professorship, Halifax, Nova Scotia, September 25, 2015

236. Detecting glaucoma structural progression with imaging, Dalhousie University, Department of Ophthalmology & Visual Sciences Visiting Professorship, Halifax, Nova Scotia, September 25, 2015

237. 36th Robert N. Shaffer Lecture, 2015 annual meeting of the American Academy of Ophthalmology, Las Vegas, NV, “Glaucoma at Low Tension: When Normal Isn’t Good Enough”, November 17, 2015

238. Introduction to the American Glaucoma Society Surgery Subspecialty Day Lecture (Michael Kass, MD), 2015 annual meeting of the American Academy of Ophthalmology, Las Vegas, NV, November 14, 2015.

239. Glaucoma at Low Tension: When Normal Isn’t Good Enough. 2015 Annual meeting of the Inter-American Course in Clinical Ophthalmology, Miami, FL, November 23, 2015.

240. Ocular perfusion pressure as a risk factor for glaucoma progression: Practical considerations. 2015 Annual meeting of the Inter-American Course in Clinical Ophthalmology, Miami, FL, November 23, 2015.

241. Visual field enhancement following surgical IOP reduction. 2015 Annual meeting of the Inter-American Course in Clinical Ophthalmology, Miami, FL, November 23, 2015.

242. Detecting Structural Progression with Imaging, 2016 Minnesota Academy of Ophthalmology, Minneapolis, MN, February 12, 2016

243. Glaucoma at low tension: When normal isn’t good enough, University of Minnesota, Minneapolis, MN, February 12, 2016.

244. Introduction to the 26th annual AGS Guest of Honor (Harry A. Quigley, MD), 2016 annual meeting of the American Glaucoma Society, Fort Lauderdale, FL, March 4, 2016

245. Introduction to the 26th annual AGS Lecturer (Anne L. Coleman, MD PhD), 2016 annual meeting of the American Glaucoma Society, Fort Lauderdale, FL, March 4, 2016

53

TEACHING: 28. Teaching Award Received: Not Applicable. 29. Teaching Specialization:

VISITING PROFESSORSHIPS: 1. Brown University School of Medicine, Providence, Rhode Island, April 6-7, 2001. 5. Wills Eye Hospital, Philadelphia, PA, October 17, 2003 6. Medical College of Wisconsin, Milwaukee, WI, November 25, 2003 7. Manhattan Eye Ear & Throat Hospital, New York, NY, January 27, 2004 8. University of Minnesota, Minneapolis, MN, October 15, 2004 9. University of Montreal, Montreal, Canada, June 2, 2005 10. University of Sherbrooke, Sherbrooke, Canada, June 3, 2005 11. University of Minnesota, Minneapolis, MN, December 22, 2005. 12. Case Western Reserve, Cleveland, OH, May 19, 2006. 13. University of Texas Southwestern Medical Center , Houston, TX, October 12, 2006 14. Baylor College of Medicine, Houston, TX, October 13, 2006. 15. North Shore-Long Island Jewish Health system, New York, NY, February 27, 2008 16. University of Illinois at Chicago, Illinois Eye and Ear Infirmary, May 9, 2008 17. University of Alabama at Birmingham, Birmingham, AL, May 8, 2009. 18. Krieger Eye Institute, Sinai Hospital of Baltimore, Baltimore, MD, February 26th,

2010. 19. University of Toronto, Toronto, Canada, March 25th, 2010. 20. New England Eye Center, Tufts University School of Medicine, June 24th, 2011 21. Wills Eye Hospital, Philadelphia, PA, May 9th 2012 22. Illinois Eye and Ear Infirmary, University of Illinois at Chicago, May 16th 2012 23. University of Colorado Hospital Eye Center, Rocky Mountain Lions Eye Institute,

Anschutz Medical Campus, Aurora, Colorado October 12 – 13th 2012. 24. New York University Medical Center, New York, NY, December 4, 2012 25. St. Louis University, St. Louis, MO, April 18, 2013. 26. Northwestern University, Chicago, IL, October 4, 2013 27. University of Iowa Hospitals and Clinics, Department of Ophthalmology and Visual

Sciences, Iowa City, IA, October 11, 2013 28. Dalhousie University, Department of Ophthalmology & Visual Sciences, Halifax,

Nova Scotia, September 25, 2015 29. University of Minnesota, Minneapolis, MN, February 12, 2016.

54

NAMED OR HONORARY LECTURES:

2006: William Evans Bruner Lecture, Case Western Reserve Medical School “Changing the Paradigm of Glaucoma Diagnosis and Monitoring”

2007: President’s Lecture, 6th annual meeting of the Optometric Glaucoma Society, Tampa, FL “Glaucoma Diagnosis and Monitoring: A Paradigm Shift”

2008: Leopold Lecture, Allergan, Inc., Irvine, CA “Glaucoma Diagnosis and Monitoring: A Paradigm Shift”

2009: 2009 Ophthalmology Alumni Sponsored Lecturer, University of Alabama Birmingham, Birmingham, AL, “Controversial Issues in Normal-Tension Glaucoma”

2010: 2010 American Glaucoma Society Clinician-Scientist Lecture, Naples, FL, “Unlocking Mysteries in Measurements of the Retinal Nerve Fiber Layer”

2010: 2010 Erwick Lecture, Krieger Eye Institute, Sinai Hospital of Baltimore, Baltimore, Maryland, “Detecting Glaucoma Progression Using Imaging”.

2011: 2011 W. Morton Grant Lecturer, New England Eye Center, Tufts University School of Medicine “Unlocking Mysteries in Measurements of the Retinal Nerve Fiber Layer”

2012: 2012 Samuel F. Schoenberg Lecture, Illinois Eye and Ear Infirmary, University of Illinois at Chicago Annual Glaucoma Symposium. “Unlocking Mysteries in Measurements of the Retinal Nerve Fiber Layer”

2012: 2012 Julius Silver Lecture, New York University School of Medicine, “Normal-Tension Glaucoma: Factors Influencing Visual Field Progression and Clinical Management Strategies”.

2013: 2013 Mansour F. Armaly Lecture, University of Iowa Hospitals and Clinics, Department of Ophthalmology and Visual Sciences, “Normal-Tension Glaucoma: Factors Influencing Visual Field Progression and Clinical Management Strategies”.

2015 2015 Robert N. Shaffer Lecture, American Academy of Ophthalmology, Las Vegas, NV, “Glaucoma at Low Tension: When Normal Isn’t Good Enough”

55

Courses and Symposiums: 1. Glaucoma: New strategies in detection & treatment, New York, NY, January, 1997. 2. Ocular blood flow abnormalities in glaucoma: 1997 annual meeting of The American

Academy of Optometry, San Antonio, Tx, December 11-13th. 3. Delayed-onset bleb-associated endophthalmitis, Bascom Palmer Eye Institute’s Trade Secrets, Miami, FL, April, 1998. 4. 34th Annual Bascom Palmer Eye Institute Resident’s Day, moderator, glaucoma section, Miami, FL, June, 1998. 5. Cupped nerves and low pressures: Is it glaucoma or neuro-ophthalmic problem? Bascom Palmer Eye Institute’s Trade Secrets, Miami, FL June, 1999. 6. Glaucoma Leaders Symposium: Charting the course of selective laser trabeculoplasty

(SLT): Sponsored by Coherent Medical Group, Colorado Springs, CO, August, 1999. 7. Imaging and measurement of optic nerve and retinal nerve fiber layer. Bascom Palmer Eye Institute’s Trade Secrets, Miami, FL, February, 2000. 8. Topographical imaging and nerve fiber layer assessment in glaucoma. International Ophthalmology Symposium of Ophthalmology – 2000, Tel Aviv, Israel, 3-2000. 9. Management of the flat anterior chamber. East Coast Glaucoma Symposium, New York, NY, 6-2000.

10. Bleb infections. East Coast Glaucoma Symposium, New York, NY, 6-2000. 11. Quantitative assessment of the retinal nerve fiber layer: Where we are and where we

are going. Brooklyn Ophthalmological Society, 01-01. 12. Cupped discs and low pressures: Clinical differentiation of glaucomatous and non- glaucomatous optic disc cupping. Brooklyn Ophthalmological Society, 01-01. 13. Corneal compensation in scanning laser polarimetry: The holy grail? International Glaucoma Society, Prague, CZ, 03-01.

14. Organizing committee, Third International Symposium on Optical Coherence Tomography, Longboat Key, Florida, 4-2001.

15. Moderator, Ocular Imaging II Poster Session, 2001 annual meeting of the Association for Research and Vision in Ophthalmology, Fort Lauderdale, Florida, 4-2001.

16. Advances in glaucoma diagnostics, Sponsored by Slack Inc., Fort Lauderdale, Florida, 4-01.

17. Ocular imaging in glaucoma: Are we there yet? Florida Society of Ophthalmology, Orlando, FL, 5-01.

18. Vascular factors in glaucoma. A national teleconference series, Palm Beach, FL 6-01. 19. Pressure Dependent and Independent Factors in Glaucoma. XXII PanAmerican

Congress of Ophthalmology, Buenos Aires, Argentina, 7-01. 20. The role of blood flow in glaucoma therapy. Clinical Applications of Blood Flow,

Jules Stein Eye Institute, UCLA School of Medicine, Los Angeles, CA, 8-01 21. Taking measure of glaucoma: Are we there yet? New Jersey Academy of

Ophthalmology, Eatontown, NJ, 10-01. 22. Dysfunctional glaucoma filtration blebs. New Jersey Academy of Ophthalmology,

Eatontown, NJ, 10-01. 23. Dysfunctional glaucoma filtration blebs. Iowa Optometric Association, Cedar Rapids,

Iowa, 10-01.

56

24. Pressure dependent and independent factors in glaucoma. Iowa Optometric Association, Cedar Rapids, Iowa, 10-01.

25. Glaucoma: A multifactorial disease. Glaucoma – A vascular perspective. 2001 Annual meeting of the American Academy of Ophthalmology, New Orleans, LA, 11-01.

26. Point-Counterpoint: Retinal nerve fiber layer is best for detection of glaucomatous structural damage. 2002 annual Royal Hawaii Eye Meeting, Kona, HI, 1-02.

27. GDx image interpretation in glaucoma. 2002 annual Royal Hawaii Eye Meeting, Kona, HI, 1-02.

28. OCT imaging in glaucoma. 2002 annual Royal Hawaii Eye Meeting, Kona, HI, 1-02. 29. Ocular imaging in glaucoma: Are we there yet? Bascom Palmer Eye Institute’s 40th

Anniversary Scientific Symposium, Miami, FL, 2-02. 30. Moderator, Optic nerve and retinal imaging in glaucoma III, 2002 annual meeting of

the Association for Research in Vision and Ophthalmology, Fort Lauderdale, FL, 5-2002.

31. Clinical recognition of the glaucomatous disc and its progression: Glaucoma 2002: Contemporary issues in glaucoma diagnosis and therapy, New York City, NY 6-02.

32. Bleb infections. Glaucoma 2002: Contemporary issues in glaucoma diagnosis and therapy, New York City, NY 6-02.

33. Inadequate IOP control after glaucoma drainage device implantation, 2002 annual meeting of the Florida Society of Ophthalmology, Miami, FL, 6-02.

34. Clinical features of the glaucomatous optic nerve, 28th Annual Kevin Hill Seminar in Ophthalmology: Glaucoma Update, Waterville, Maine, 7-02.

35. Exfoliation Glaucoma, 28th Annual Kevin Hill Seminar in Ophthalmology: Glaucoma Update, Waterville, Maine, 7-02.

36. Cyclodestructive procedures, 28th Annual Kevin Hill Seminar in Ophthalmology: Glaucoma Update, Waterville, Maine, 7-02.

37. Combined cataract extraction and trabeculectomy: How I do it. 28th Annual Kevin Hill Seminar in Ophthalmology: Glaucoma Update, Waterville, Maine, 7-02.

38. Normal-tension glaucoma: Does it exist? 28th Annual Kevin Hill Seminar in Ophthalmology: Glaucoma Update, Waterville, Maine, 7-02.

39. Advances in retinal nerve fiber layer analysis and practice, Sponsored by Slack, Inc., 2002 Annual meeting of the American Academy of Ophthalmology, Orlando, FL, 10-02.

40. Scanning laser imaging of the optic nerve and retinal nerve fiber layer, 2002 Annual meeting of the American Academy of Ophthalmology (skills transfer pgm), Orlando, FL, 10-02.

41. Should I buy an optic nerve or nerve fiber layer imaging device for my practice? 2002 Annual meeting of the American Academy of Ophthalmology (Controversies in Ophthalmology, spotlight session), Orlando, FL, 10-02.

42. New Evidence, New Treatments: The impact of National Eye Institute Clinical Trials on Glaucoma Management, 2002 annual meeting of the New York Society of Clinical Ophthalmology, New York, NY, 12-02.

43. Moderator, Controversies in glaucoma: Battle on the beach. Miami, FL, 2-02.

57

44. Chair, Glaucoma 2003 Subspecialty Day Program: Glaucoma 2003 Trials and Tribulations

45. Co-Chair, 2003 International Society for Imaging in the Eye, Ft. Lauderdale, FL, 5-03.

46. Moderator, Optic nerve and retinal nerve fiber layer imaging II, 2003 annual meeting of the Association for Research in Vision and Ophthalmology, Fort Lauderdale, FL, 5-2003.

47. The normal-tension glaucoma study: Can I save the sight of my patient? Glaucoma 2003, Chicago, IL, 6-03.

48. The normal-tension glaucoma study: Can I save the sight of my patient? Glaucoma 2003, Chicago, IL, 6-03.

49. Scanning laser imaging of the optic nerve and retinal nerve fiber layer, 2003 Annual meeting of the American Academy of Ophthalmology (skills transfer pgm), Anaheim, CA,11-03

50. Chair, Ocular Imaging 2004, Palm Beach, FL, 12-03. 51. Moderator, Battle on the Beach II, Palm Beach, FL, 2-04 52. Selective Laser Trabeculoplasty: Fact and Fiction, Battle on the Beach II, Palm

Beach, FL 2-04 53. Target IOP: An evidence-based approach. Update on Therapeutic Treatments in

Glaucoma, Chicago, IL, 4-04. 54.Imaging in glaucoma: Evolution and revolution. Update on Therapeutic Treatments in

Glaucoma. Chicago, IL, 4-04. 55. Clinical assessment of the glaucomatous optic nerve damage. Update on Therapeutic

Treatments in Glaucoma. Chicago, IL, 4-04. 56. Co-Chair, 2004 International Society for Imaging in the Eye, Ft. Lauderdale, FL, 4-

04. Ft. Lauderdale, FL. 57. Moderator, Optic nerve and retinal nerve fiber layer imaging II, 2004 annual meeting

of the Association for Research in Vision and Ophthalmology, Fort Lauderdale, FL, 4-04.

58. Early experience with Glaucoma Progression Analysis, Glaucoma 2004, New York, NY, 6-04

59. Assessment of glaucomatous disc damage and RNFL atrophy in clinical practice, Glaucoma 2004, New York, NY, 6-04

60. Ocular Imaging in Glaucoma: Does it add to clinical care? Thorny Issues in Ophthalmology, Portland, OR, 6-04

61. Target IOP calculation: Pearls and Pitfalls. Thorny Issues in Ophthalmology, Portland, OR, 6-04.

62. Imaging in glaucoma: Does it add to clinical care? Michigan Ophthalmologic Society, Detroit, MI, 9-04

63. The 5 R’s in glaucoma diagnosis. Focusing Ophthalmology on Reframing Glaucoma Evaluation (FORGE). Boca Raton, FL, 9-04

64. Chair, Focusing Ophthalmology on Reframing Glaucoma Evaluation (FORGE). Miami, FL, 9-04.

65. Chair, 2004 Glaucoma Subspecialty Program, American Academy of Ophthalmology, New Orleans, LA, 10-04

58

66. Optical coherence tomography for glaucoma diagnosis and monitoring, Scanning laser imaging of the optic nerve and nerve fiber layer, 2004 annual meeting of the American Academy of Ophthalmology, New Orleans, LA, 10-04

67. Chair, Imaging 2005, West Palm Beach, FL 12-04. 68. Imaging My Way, Kombat on the Key Glaucoma Forum, 1-05 69. Chair, Focusing Ophthalmology on Reframing Glaucoma Evaluation (FORGE),

Chicago, IL 2-05. 70. Chair, Focusing Ophthalmology on Reframing Glaucoma Evaluation (FORGE),

Miami, FL, 3-05. 71. How do I use imaging devices to diagnose glaucoma and monitor progression?

American Society of Cataract and Refractive Surgery (ASCRS) 2005 Glaucoma Day, Washington D.C., 4-05

72. Should everyone receive an antifibrosis agent during trabeculectomy? American Society of Cataract and Refractive Surgery (ASCRS) 2005 Glaucoma Day, Washington D.C., 4-05

73. Should we retire ocular beta-blockers for initial glaucoma monotherapy? American Society of Cataract and Refractive Surgery (ASCRS) 2005 Glaucoma Day, Washington D.C., 4-05

74. Tubes and Trabs: How to choose. 2005 Anterior segment update. University of Pittsburgh Medical Center, Pittsburgh, PA, 5-05.

75. Imaging Update. 2005 Anterior segment update. University of Pittsburgh Medical Center, Pittsburgh, PA, 5-05.

76. Optic disc documentation. Association of International Glaucoma Societies, Vienna, Austria, 7-05.

77. Scanning laser polarimetry for glaucoma diagnosis. Association of International Glaucoma Societies, Vienna, Austria, 7-05.

78. Treatment of risk in the glaucoma continuum. Washington DC, 9-05. 79. Examination of the optic nerve and nerve fiber layer: basic and advanced techniques.

Glaucoma Fellows Educational Symposium, Irvine, CA, 9-05. 80. Treatment of risk in the glaucoma continuum, Miami, FL, 11-05 81. Is imaging ready for clinical practice, 2nd annual glaucoma forum, Fort Worth, TX,

11-05. 82. Moderator, Imaging 2006, West Palm Beach, FL, 12-05. 83. Controversies in normal-tension glaucoma, Battle on the Beach, Key Biscayne, FL 2-

06. 84. Glaucoma diagnosis by optic disc evaluation, 2006 World Ophthalmology Congress,

International Congress of Ophthalmology, Sau Paulo, Brazil, 2-06. 85. Co-chair, 2006 International Society for Imaging in the Eye, Ft. Lauderdale, FL, 4-06.

Ft. Lauderdale, FL. 86. Controversies in normal-tension glaucoma. Wilmer Eye Institute, Johns Hopkins

University School of Medicine, Current Concepts in Ophthalmology, Vail, Colorodo, 3-06.

87. Glaucoma drainage devices. Wilmer Eye Institute, Johns Hopkins University School of Medicine, Current Concepts in Ophthalmology, Vail, Colorodo, 3-06.

88. Chair, 2006 American Glaucoma Society Minisymposium: Glaucoma in the presence of retinal disease, Charleston, SC, 3-06.

59

89. The future of structural testing in glaucoma, World Glaucoma Forum, Beijing, China, 3-06.

90. Primary laser trabeculoplasty for glaucoma management, Glaucoma 2006, NY, NY, 6-06

91. Practical applications of imaging in glaucoma, Houston, TX, 10-06 92. Detection of Structural Glaucomatous Progression. 6th annual meeting of the

International Glaucoma Symposium, Athens, Greece, 3-07. 93. Beyond IOP lowering: The Low-Pressure Glaucoma Treatment Study. 6th annual

meeting of the International Glaucoma Symposium, Athens, Greece, 3-07. 94. Chair, 2007 American Glaucoma Society Minisymposium: Glaucoma in the presence

of uveitis, San Francisco, CA, 3-07 95. Clinical biomarkers predictive of progression. 2nd annual meeting of the Association

of International Glaucoma Societies/World Glaucoma Congress, Singapore, 7-07. 96. Glaucoma progression in clinical practice: disc photography and imaging. 2nd annual

meeting of the Association of International Glaucoma Societies/World Glaucoma Congress, Singapore, 7-07.

97. Integrating case management with optic nerve imaging. 2nd annual meeting of the Association of International Glaucoma Societies/World Glaucoma Congress, Singapore, 7-07.

98. Assessment of retinal ganglion cell protection: clinical trials and clinical practice. 2nd annual meeting of the Association of International Glaucoma Societies/World Glaucoma Congress, Singapore, 7-07.

99. GDx-VCC imaging for glaucoma diagnosis and monitoring. 2nd annual meeting of the Association of International Glaucoma Societies/World Glaucoma Congress, Singapore, 7-07.

100. Management of dysfunctional glaucoma filtration blebs. 6th Downeast Ophthalmology Symposium, Bar Harbour, Maine, 10-07.

101. Practical approach to imaging for glaucoma diagnosis and monitoring. 6th Downeast Ophthalmology Symposium, Bar Harbour, Maine, 10-07.

102. Controversies in normal-tension glaucoma. 6th annual meeting of the Optometric Glaucoma Society, Tampa, FL, 10-07.

103. Identifying glaucoma structural progression in clinical practice. Presented at the 2007 annual meeting of the American Academy of Ophthalmology, New Orleans, LA, 11-07.

104. Co-Chair, Integrating imaging with case management. 2007 annual meeting of the American Academy of Ophthalmology, New Orleans, LA, 11-07.

105. Chair, 2008 American Glaucoma Society Minisymposium: 40 Years of Aqueous Drainage Implants: New Devices and New Data, Washington DC, 3-07.

106. Normal-tension glaucoma: Clinical challenges and new therapeutic concepts; presented at the 2008 annual meeting of the International Perimetry Society, Nara, Japan, 5-08.

107. Surgical approach in normal-tension glaucoma; presented at the East Coast Glaucoma Symposium, New York, NY, 6-08.

108. Assessment of glaucomatous structural progression; presented at the East Coast Glaucoma Symposium, New York, NY, 6-08.

60

109. Moderator, Diagnostic Testing in Glaucoma, 2008 annual meeting of the American Academy of Ophthalmology, Glaucoma Subspecialty Day symposium, Atlanta, GA, 11-08.

110. Focusing Ophthalmology on Reframing Glaucoma Evaluation (FORGE) 3: Detection and Management of Glaucoma Progression, 2008 annual meeting of the American Academy of Ophthalmology, Atlanta, GA, 11-08.

111. Integrating Imaging with Clinical Practice, 2008 annual meeting of the American Academy of Ophthalmology, Atlanta, GA, 11-08.

112. Co-Chair, East Coast Glaucoma Symposium, Atlanta, GA, 11-08. 113. Surgical Alternatives to Trabeculectomy, East Coast Glaucoma Symposium, Atlanta,

GA, 11-08. 114. Chair, Detection and Management of Glaucoma Progression, 2009 Annual meeting

of the American Glaucoma Society, San Diego, CA, 3-09. 115. Co-Chair, Use of Imaging for Glaucoma Diagnosis and Monitoring, 2009 Annual

meeting of the American Glaucoma Society, San Diego, CA, 3-09. 116. Co-Chair, Local Organizing Committee, World Glaucoma Congress, July 8-11 2009,

Boston, MA. 117. Detecting glaucoma progression with OCT, CSLO, and SLP – today and tomorrow,

2009 World Glaucoma Congress, Boston, MA, 7-09. 118. Structure and functional parameters that predict progression, 2009 World Glaucoma

Congress, Boston, MA, 7-09. 119. Differential diagnosis and diagnostic evaluation of low-pressure glaucoma, 2009

World Glaucoma Congress, Boston, MA, 7-09. 120. Optic disc photography for assessment of glaucoma progression, 2009 World

Glaucoma Congress, Boston, MA, 7-09. 121. Spectral domain OCT imaging for early glaucoma diagnosis, 2009 World Glaucoma

Congress, Boston, MA, 7-09. 122. Co-Chair, Midwest Glaucoma Symposium, Chicago, IL, 10-09. 123. Why is Trabeculectomy My Preferred Initial Surgery for OAG, 2009 annual meeting

of the American Academy of Ophthalmology, Glaucoma Subspecialty Day symposium, San Francisco, CA, 10-09.

124. Clinical Significance of Early Glaucoma Diagnosis, 2009 annual meeting of the American Academy of Ophthalmology, San Francisco, CA, 10-09.

125. Integrating Imaging with Clinical Practice, 2009 annual meeting of the American Academy of Ophthalmology, San Francisco, CA, 10-09.

126. Co-Chair, Florida Glaucoma Society Autumn annual meeting, Surgical Innovation in Glaucoma (Christopher Girkin MD, honored guest), Miami, FL, 10-09.

127. Chair, Glaucoma Section, 5th International Conference on Ocular Infection, February 18-21 2010 Palm Beach, FL

128. Moderator, Bascom Palmer Eye Institute Glaucoma Mid-Winter Symposium, Glaucoma Cup of the Americas, January 30th, 2010, Miami FL.

129. Co-Chair, First Annual American Glaucoma Society Surgery Day, March 4 2010, Naples, FL.

130. Section Co-Chair, 7th World Glaucoma Association Consensus Meeting on Medical Therapy of Glaucoma, May 1st 2010, Fort Lauderdale, FL.

61

131. Moderator, New Insights into Disease Progression, Annual Meeting of the Association for Research and Vision in Ophthalmology, May 3rd 2010, Fort Lauderdale, FL.

132. Co-Chair, Florida Glaucoma Society Spring annual meeting, Neuroprotection in Glaucoma: myth or new goal (L. Jay Katz MD, honored guest), Fort Lauderdale, March 2nd 2010, Fort Lauderdale, FL.

133. Why should we detect and treat pre-perimetric glaucoma? 2010 annual meeting of the American Academy of Ophthalmology, Glaucoma Subspecialty Day symposium, Chicago, IL, 10-10.

134. Trabeculectomy: How I do it. 2010 Annual meeting of the American Academy of Ophthalmology, Chicago, IL, October 17, 2010.

135. Co-Chair, Florida Glaucoma Society Fall annual meeting, Disc hemorrhage, parapapillary atrophy and glaucoma progression (Jeffrey Liebmann, MD, honored guest), November 23, 2010, Delray Beach, FL

136. Chair, 21st annual meeting of the American Glaucoma Society, March 2-6, 2011, Dana Point, CA.

137. The Low-Pressure Glaucoma Treatment Study, annual meeting of the Asia Pacific Academy of Ophthalmology, Sydney, Australia, March 21, 2011.

138. Co-Chair, Florida Glaucoma Society Spring annual meeting. CCT, tonometry, ocular biomechanics, and glaucoma risk – How does it all fit together? (James Brandt, MD, honored guest), April 28th, 2011, Miami, FL

139. Co-Chair, Florida Glaucoma Society Fall annual meeting. Discovering new (and re-discovering old) therapeutic targets for POAG (Louis Pasquale, MD, honored guest), November 17, 2011, Fort Lauderdale, FL

140. Moderator, Bascom Palmer Eye Institute’s 50th Anniversary Scientific Meeting, Diagnostic Imaging and Functional Testing: Which Tests and When? February 3rd 2012, Miami, FL.

141. Chair, 22nd annual meeting of the American Glaucoma Society, March 1-4 2012, New York, NY.

142. Factors influencing visual field progression and clinical management strategies in normal-tension glaucoma, 116th annual meeting of the Japanese Ophthalmological Society, April 5th 2012, Tokyo, Japan,

143. Neuroprotection: What is it, Why do we need it, How do we measure it? Glaucoma 2.0, January 26th 2013, Bascom Palmer Eye Institute, Miami, FL.

144. Moderator, Achieving IOP targets in clinical practice, March 1, 2013, 2013 annual meeting of the American Glaucoma Society, San Francisco, CA

145. Advanced Imaging Techniques in Glaucoma, October 4th 2013, Northwestern University Ocular Imaging Course, Chicago, IL.

146. Moderator, Detecting glaucoma progression using visual fields and imaging, March 1, 2014, annual meeting of the American Glaucoma Society, Washington DC.

147. Moderator, Confound It! Interpreting Glaucoma Testing in the Presence of Other Diseases, 2014 annual meeting of the American Academy of Ophthalmology, Glaucoma Subspecialty Day symposium, Chicago, IL, 11-14

148. Chair, Glaucoma Progression Plenary Session, 6th World Glaucoma Congress, Hong Kong, June 9, 2015.

62

149. The Future of Ocular Imaging, Atlantic Eye Symposium, Halifax, Nova Scotia, 9-25-15.

150. Glaucoma at Low Tension: When Normal Isn’t Good Enough. 2015 Annual meeting of the Inter-American Course in Clinical Ophthalmology, Miami, FL, November 23, 2015.

151. Ocular perfusion pressure as a risk factor for glaucoma progression: Practical considerations. 2015 Annual meeting of the Inter-American Course in Clinical Ophthalmology, Miami, FL, November 23, 2015.

152. Visual field enhancement following surgical IOP reduction. 2015 Annual meeting of the Inter-American Course in Clinical Ophthalmology, Miami, FL, November 23, 2015.

FELLOWS TRAINED:

1. Harmohina Bagga MD: June 2001 – July 2004. Research Fellow. Present position, private practice, Beverly Hills, CA.

2. Max Villain MD, PhD: June 2001 – 2002. Research Fellow. Professor of Ophthalmology, Montpellier, France.

3. Omar N. Piovanetti-Perez, MD: June 2003 – January 2004. Research Fellow. Present position, Private practice, San Juan, Puerto Rico.

4. Constance Guaqueta, MD: January 2004 – June 2005. Research Fellow. Present position, private practice, Boston, MA.

5. Sarah Wellik, MD: July 2004 - June 2005. Present position: Assistant Professor of Clinical Ophthalmology, University of Miami Miller School of Medicine, Bascom Palmer Eye Institute, Plantation, FL.

6. Maria Pinzon-Plazas, MD: June 2004 – July 2006. Present position, private practice, Bogota, Columbia.

7. Mitra Sehi OD PhD: June 2004 – July 2008. Research Fellow. Present position, Research Assistant Professor of Ophthalmology, University of Miami Miller School of Medicine, Bascom Palmer Eye Institute, Palm Beach Gardens, FL

8. Stephen Ume, MD: July 2005 – June 2006. Present position: Private practice, Florida Eye Clinic, Nigeria, Africa.

9. Dilraj Grewal MD: June 2006 – June 2010. Present Position: Ophthalmology Residency, Northwestern University School of Medicine, Chicago, IL.

10. Krishna Kishor, MD: July 2006 – June 2007. Present position: Assistant Professor of Clinical Ophthalmology, University of Miami Miller School of Medicine, Bascom Palmer Eye Institute, Palm Beach Gardens, FL.

11. Clinton Sheets, MD: July 2007 – June 2008. Present position: Private practice, Tampa, FL.

12. Margot Goodkin, MD, PhD: July 2008 – June 2009. Present Position: Medical Officer, Food and Drug Administration, Medical Device Panel, Washington D.C.

13. James Paauw, MD: July 2009 – June 2010. Present Position: Glaucoma Fellow. 14. Jonathon Erickson, MD: July 2010 – June 2011. Present Position: Private practice,

Minneapolis, MN. 15. Maggie Hymowitz, MD: July 2010 – June 2011. Present Position: Private practice,

Philadelphia, PA. 16. Namita Bhardwaj, MD: July 2010 – June 2011. Present Position: Ophthalmology

residency training, Tulane University, New Orleans, LA 17. Maria Cecilia Reyes, MD: July 2010 – March 2011. Present Position: Pathologist, St.

Barnabas Medical Center, Livingston, NJ.

63

18. Yun Suk Chung, MD: August 2010 – August 2011. Present Position: Chair, Department of Ophthalmology, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang, Korea

19. Phillip I. Niles, MD: June 2011 – January 2012. Present Position: Ophthalmology Residency, Department of Ophthalmology & Visual Sciences, University of Iowa, Iowa City, Iowa.

20. Amy Martino, MD: July 2011 – June 2012. Present Position: Private Practice, Tampa, FL 21. Ben Harvey, MD: July 2011 – June 2012. Present Position: Private Practice, Oklahoma

City, OK 22. Shawn Iverson, DO: July 2011 – June 2013. Present Position: Ophthalmology Resident,

University of South Carolina, Columbia, SC 23. George Papachristou, MD: July 2012 – June 2013: Assistant Professor of

Ophthalmology, Penn State Hershey Eye Center, Hershey, PA 24. Scott Schultz, MD: July 2012 – June 2013: Private Practice, Hilton Head, SC 25. Iman Goharian, MD: July 2012 – Present: Research Fellow 26. Tracy Wright, MD: July 2013 – June 2014. Present Position: Assistant Professor of

Ophthalmology, Bascom Palmer Eye Institute, University of Miami School of Medicine, Miami, FL

27. Arindel Maharaj, MD, PhD: July 2013 – June 2014. Present Position: Assistant Professor of Ophthalmology, Bascom Palmer Eye Institute, University of Miami School of Medicine, Miami, FL

28. Anthony Greer, MD: July 2014 – June 2015; Present Position: Private Practice, Ashville, NC

29. Justin Shaw, MD: July 2014 – June 2015: Present Position: Private Practice, Eye Consultants of Pennsylvania, Reading, PA

30. James Pitts, MD: July 2015 – June 2016: Glaucoma Fellow 31. Azra Idrizovic, MD: July 2015 – June 2016: Glaucoma Fellow

64

30. Thesis and Dissertation Advising: Dissertation Committee for Xiang-Run Huang, Department of Biomedical Engineering, University of Miami, Coral Gables, completed June, 2000. SERVICE: 31. University Committee and Administrative Responsibilities:

Committee Assignments: 1. Resident selection committee, New England Eye Center, 1993.

2. Curriculum committee, New England Eye Center, 1993. 3. Resident advisory board, The Ophthalmology Resident (Slack, Inc., Thorofare, NJ), 1993-94.

4. Pharmacy committee, The New York Eye and Ear Infirmary, 1996 - 1997. 5. Telemedicine committee, The New York Eye and Ear Infirmary, 1996 - 1997.

6. Infection control committee, The New York Eye and Ear Infirmary, 1996 - 1997. 7. Library committee, The New York Eye and Ear Infirmary, 1996 - 1997.

8. Fellowship committee, The New York Eye and Ear Infirmary, 1996 - 1997. 9. Technology assessment committee, American Academy of Ophthalmology, 2003. 10. Glaucoma Subspecialty Day Committee, American Academy of Ophthalmology,

2003 – 2009. 11. Glaucoma Education Committee, EyeCare America, Foundation of American

Academy of Ophthalmology, 2004 – 2007. 12. Chair, Bylaws and Strategic Planning Committee, American Glaucoma Society,

2005 – 2009. 13. Chair, Scientific Program Committee, American Glaucoma Society, 2010 – 2012. 14. Governing Board, Bascom Palmer Eye Institute of the Palm Beaches, 2006 – Present 15. Microbiology Committee, Bascom Palmer Eye Institute of the Palm Beaches, 2006 –

Present 16. Medical Advisory Committee, The Glaucoma Foundation, 2007 – Present. 17. Co-chair, American Glaucoma Society Operations Task Force, 2007 – 2008 18. Interim Medical Director, Bascom Palmer Eye Institute of the Palm Beaches, 2006. 19. Chair, Medical Records Task Force, Bascom Palmer Eye Institute, 2007 – 2008. 20. Nominating Committee, American Glaucoma Society, 2007 – 2009. 21. Co-Chair, Local Organizing Committee, World Glaucoma Congress, July 8-11 2009,

Boston, MA. 22. Chair, Bylaws Committee, World Glaucoma Association, 2009 – Present. 23. Chair, Scientific Program Committee, American Glaucoma Society, 2011-2012

(member 2005 – Present). 24. Consensus Development Panel, World Glaucoma Association 7th Consensus, Medical

Treatment of Glaucoma (2010). 25. Member, Scientific Advisory Board, The Glaucoma Research Foundation, 2012 –

Present. 26. Vice-President, American Glaucoma Society, 2013-2014 27. Director, American Glaucoma Society Foundation, 2012-Present

65

28. President and CEO, American Glaucoma Society, 2015-2016 29. President and CEO, American Glaucoma Society Foundation, 2015-2016

66

Scientific Journal Reviews: 1. American Journal of Ophthalmology 2. Archives of Ophthalmology 3. Ophthalmology 4. Journal of Glaucoma 5. Survey of Ophthalmology 6. Ophthalmic Surgery, Lasers and Imaging 7. Eye 8. British Journal of Ophthalmology 9. Current Eye Research 10. European Journal of Ophthalmology 11. Investigative Ophthalmology and Visual Science NATIONAL EYE INSTITUTE STUDY SECTION: 2002 – Present: Ad hoc committee member Board Examiner: Associate Examiner, American Board of Ophthalmology, 1999 - Present.

32. Community Activities: Not Applicable.

Date post:	11-Nov-2018
Category:	Documents
Upload:	dotuong
View:	213 times
Download:	0 times

CURRICULUM VITAE - University of...

Documents